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Abstract 
Arthroscopic surgical procedures aiming to regenerate maxillofacial tissues are 
troubled by its complex structures and challenging surgical access. Indeed, while 
minimal invasive procedures that deliver regenerative materials and/or cells are 
common in articulating joints such as the knee, there are currently no standardised 
treatments that place cells, regenerative factors or materials into maxillofacial tissues 
to foster bone, cartilage or muscle repair. This project aimed to develop hyaluronic 
acid (HA)-based hydrogels, which are suitable for use in minimally invasive 
procedures, that can adhere to the surrounding tissue, and deliver cells and drugs. 
Consequently, cells produce cartilage-specific extracellular matrix (ECM) 
components to replace the hydrogel with, resulting in neo-tissue. This effect might be 
further increased by introduction of Dimethyloxalylglycine (DMOG). 
Modifying HA with both methacrylate (MA) and 3,4-dihydroxyphenylalanine (Dopa) 
groups using a completely aqueous synthesis route, MA-HA-Dopa hydrogels can be 
applied under aqueous conditions, gel quickly using a standard surgical light, and 
adhere to tissue. Moreover, upon oxidation of the Dopa, human marrow stromal cells 
(hMSC) attach to hydrogels and survive when encapsulated within them. In order to 
assess the formation of extracellular matrix components, non-canonical amino-acid 
tagging (FUNCAT) with Raman spectral imaging have been utilised.               
Combining those, 3D spectral and fluorescence maps of cells and their secreted ECM 
allow qualitative and quantitative analysis. FUNCAT and Raman are unbiased, 
inexpensive and rapid techniques. Results show peptides/proteins being secreted, 
with them accumulating in the immediate space around the plasma membrane. 
Depending on the hydrogel formulation, DMOG did increase quantity as well as 
distance of newly synthesised peptides/proteins being detected away from the cell 
membrane. The overall findings suggest that MA-HA-Dopa hydrogels may find use in 
minimally invasive procedures to foster maxillofacial tissue repair.  
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1 Introduction to Thesis 
Osteochondral defects are classified as diseases/damage to the bone (Greek ‘osteo’) 
and cartilage (Greek ‘chondro’) components of all bodily joints. First, general 
osteochondral defects, treatment and research on joints are described (see 1.1), 
followed by focus on the temporomandibular joint exclusively (see 1.2, page 23). 
 
1.1 General osteochondral defects 
Osteochondral lesions and defects can appear in any bodily joint, with highest rate of 
occurrence in knee and ankle. The management of articular cartilage defects 
represents a common clinical problem for orthopaedic surgeons. This appears 
especially problematic as articular cartilage has limited healing capacity, resulting in 
rapid deterioration following trauma or degenerative pathology. Such damages are 
ultimately leading to joint pain, functional impairment and degenerative arthritis.[1, 2]  
 
1.1.1 Current clinical approaches 
The gold-standard for terminal osteochondral lesions is common total joint 
replacement.[2] However, the use of inorganic artificial joint materials like metals or 
ceramics are limited by their insufficient mechanical and bioactive properties.        
Such artificial joints require extensive surgery and need replacement after several 
years.[3, 4] Restoring living structural tissue in early-stage osteochondral defects is 
merely based on autograft or allograft transplantation. This comes with drawbacks 
like host-graft rejection, donor pain as well as insufficient donor availability.[5]    
Further clinical treatments for osteochondral defects are common methods since late 
1970’s and include debridement, bone marrow stimulation techniques like 
microfracturing, autologous chondrocyte implantation (ACI) and osteochondral 
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transplants like mosaicplasty (see Figure 1).[2, 6] However, these techniques not 
always reach a fully curative solution. 
 
Figure 1: Treatment algorithm for defects of articular cartilage. [2] 
Depending on the location of the lesion, surgeons assess symptoms and lesion size. 
Considering the lifestyle of the patient and previous therapy will identify possible 
surgical treatments. 
 
1.1.2 Tissue engineering for osteochondral defects 
Over the last decades, tissue engineering (TE) has emerged as promising approach 
for a wide range of medical areas. This is especially true for osteochondral defects, 
as cartilage is known to have no natural healing response.[7] Still, TE seems to have 
great potential to fully functionally and structurally regenerate tissue.                               
TE-based techniques currently used in clinical applications include Matrix-induced 
autologous chondrocyte implantation (MACI)[8] and scaffolds inspired by natural 
tissue components (i.e. Hyaluronic-acid-based scaffolds).[2] MACI is the most 
common technique. Similar to autologous chondrocyte implantation, it requires two 
separate surgical procedures, one to isolate the cells and one to implant the 
processed cells with the scaffold into the patient. Although several publications 
reported good clinical outcome [9, 10], there is only limited proof for superiority of this 
technique over existing treatments. 
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In order to address the lack of efficient care, research has focused on cell-only 
strategies, as well as TE-based approaches including material-only strategies and 
combined cell-material strategies.[11]  
Cell-only approaches rely on a range of different cell types. These can be delivered 
directly via procedures like microfracturing (mesenchymal stem cells) as well as 
harvested autologous or allogenic and delivered to the injury site (i.e. chondrogenic 
cells). Providing mature chondrocytes has shown better extracellular matrix (ECM) 
production over using progenitor cells [12], although delivering chondrocytes has 
several disadvantages over mesenchymal progenitors. Chondrocytes require a 
separate surgical procedure harvesting them, with biopsies resulting in low cell yields. 
Furthermore, isolating and cultivating mature chondrocytes can trigger 
dedifferentiation which drives them to lose their cartilage-like phenotype.[13]       
Hence, mesenchymal stem cells have gained more focus as they are abundant, 
regenerate and potentially allow single-procedure approaches via microfracturing 
techniques. Another key characteristic is their differentiation potential, allowing them 
to assume different cell types. Well-established methods relying on soluble factors 
are in place to drive stem cell fate in 2D. For chondrogenic differentiation, these 
factors include hypoxia as well as bone morphogenic proteins 2 and 4 (BMP-2, BMP-
4) [14-16], fibroblast growth factor 2 (FGF-2) [17] and transforming growth factor β1 
(TGF-β1) [18]. Interestingly, some of these chondrogenic factors are also able to 
induce osteogenesis, f.e. BMP-2 [18, 19] or TGF-β1 [18]. Various groups, including 
Taheem and colleagues, have investigated the importance of physiological oxygen 
content for chondrogenesis, by lowering oxygen levels to the natural hypoxic 
concentration of 0.5 – 10 % in mature cartilage.[20] This was achieved 
pharmacologically by addition of hypoxia inducible factor-1α hydroxylase inhibitor 
Dimethyloxalylglycine (DMOG) to human bone-marrow derived mesenchymal stem 
cells.[21-23] DMOG acts as pan-hydroxylase inhibitor, which leads to an upregulation 
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of hypoxia-inducible factor (HIF).[21, 24] However, delivering these agents and 
stabilising cells within the defect has proven challenging. Anchoring cells in place was 
tested with fibrin [25] and cell aggregates [26], but still, this reached low stability, 
rendering regeneration of larger defect areas troublesome. Overall, cell-only 
approaches are difficult to shape to the volume needed and are at risk of being 
separated from the defect site before tissue regeneration has happened, as there is 
little to no material holding cells in place. 
Material-only strategies are based on the concept of cell recruitment of cells present 
in the immediate surrounding of the material. Most approaches rely on the migration 
of progenitor cells, i.e. bone-marrow derived mesenchymal stem cells, which can 
infiltrate the site via microfractures. To fully regenerate the tissue, materials are often 
designed to be fully biodegradable, leaving only the ECM produced by the cells. It is 
hypothesised, that materials providing cell adhesion points may drive proliferation and 
differentiation via mechanical cues like stiffness or topography. Such materials can 
be either synthetic or derived from natural materials. Natural biomaterials including 
chitosan, various collagens, alginate, bacterial polymers or hyaluronic acid (HA) have 
proven promising for TE purposes.[27] Although, mechanically weaker than their 
synthetic counterparts, natural polymers can facilitate cellular responses like cell 
attachment via integrins (i.e. collagens) or cell survival via CD44 (i.e. HA). As such, 
these materials can be exploited in different forms ranging from sponges, sheets to 
hydrogels. Utilising a collagen scaffold, Wang and colleagues delivered an anti-
inflammatory compound into osteochondral defects in rabbits.[28] Their material 
managed to recruit cells and lower the overall inflammatory response, leading to 
production of neo-cartilage. Sofu and colleagues have investigated the regenerative 
potential of HA-based scaffolds via microfracturing.[29] This comparative study has 
reported repair tissue by magnetic resonance observation, however, long term 
performance of this neo-tissue in vivo is yet to be confirmed. As osteochondral defects 
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in the knee often involve both cartilage and bone, multi-layered techniques have been 
investigated. MaioRegen® by JRI Orthopaedics is composed of three layers – a 
collagen layer for cartilage, a collagen layer enriched with hydroxyapatite for calcified 
cartilage and a layer of hydroxyapatite for subchondral bone.[30] Although, new 
lineage specific tissues have formed, the quality and integration of the graft into the 
surrounding tissue lacked conclusive evidence, as shown by Brix et.al.[30]              
Other products like TruFit™ by Smith+Nephew Endoscopy, are based on poly-lactide 
glycolide, which mimics the macro-structure of bone. However, results were not 
convincing of better clinical outcome over mosaicplasty.[31] Considering all those 
results, material-only techniques seem to suffer from issues related to defect size, as 
cell migration is often limited and therefore cells might not be able to repopulate the 
whole implant. 
Combined cell-material strategies have benefits over cell-only and material-only 
approaches. Encouraging here are materials that are applied to the defect side as 
solids or such that are delivered as solutions and are solidified after application.                 
Solid materials can be shaped upfront and moulded specifically for the injury site.         
3D-printing techniques have emerged as promising for such purposes.[32-35] 
Modern printers are able to encapsulate cells as well as bioactive components. 
Injectable compositions, like hydrogels, are also capable of delivering cells and 
biological active components and can be shaped on site. As described for the 
material-only TE approaches, a wide range of synthetic and natural polymers have 
been utilised. Alginate has been used widely as basic hydrogel material for 
osteogenic regeneration. It is cheap and easy to produce, and due to its electrical 
charge, it can cross-link quickly with cations (i.e. Ca2+). Alginate hydrogels were used 
to encapsulate mature chondrocytes in spheres, which resulted in an increase in cell 
number as well as upregulation of chondrogenic genes.[36] Fonseca and colleagues 
have encapsulated human MSCs in MMP-degradable Alginate hydrogels.[37] 
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Subcutaneous implantation in severe combined immunodeficiency(SCID)-mice has 
shown cartilage-like tissue after 4 weeks. Further materials like Chitosan, have been 
used for hydrogel production. Chitosan hydrogel as carrier, was mixed with cartilage 
ECM components type-II collagen and chondroitin sulphate.[38] Encapsulating either 
mature chondrocytes or progenitor MSCs, lead to increase cell condensation as well 
as cartilage like ECM secretion, for both cell types. As one of the most abundant ECM 
components, collagen is a prominent candidate amongst hydrogels. Muhonen and 
colleagues synthesised a recombinant human type-II collagen based hydrogel, 
allowing a xeno-free and donor-free production.[39] They concluded, that when 
encapsulating high density pellets of human bone marrow derived mesenchymal 
stem cells, cartilage-like ECM is secreted after 84 days in chondrogenic induction 
media. Another common natural material for hydrogel formation is hyaluronic acid. 
Modifying HA with the catechol group tyramine, allowed cross-linking between HA 
macromers upon introduction of oxidising agents, here hydrogen peroxide and 
horseradish peroxidase.[40] Encapsulating mesenchymal stem cells showed reduced 
quantity of cells over time. Cell condensation of the remaining cells seems to play a 
significant role for chondrogenesis. Other groups have further increased the 
complexity of hydrogels used, by using two or more materials, incorporate multiple 
cell types or provide a wide range of soluble bioactive components.[41-44]  
Inflammatory responses to Temporomandibular Joint disorders (TMDs) may 
accelerate TMJ cartilage erosion and disease progression (see 1.2.2, page 25).[45] 
Considering this, immunomodulatory effects of type-I collagen upon mature 
chondrocytes has been investigated.[46] Similarly to the material-only approach by 
Wang and colleagues [28], Yuan and team have encapsulated neonatal rabbit 
chondrocytes in collagen hydrogels and incubated for up to 28 days in vitro. 
Introduced lymphocytes mimicked a natural immune response, potentially leading to 
a dedifferentiation of the chondrocytes and therefore a reduced production of 
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cartilage-like ECM. However, type-I collagen hydrogels appeared to exert regulatory 
effects on immune cells and increased the synthesis of ECM proteins.  
Though promising progress has been made creating neo-cartilage in vitro as well as 
in vivo, the integration of cartilage into the surrounding tissue is a common problem 
in osteochondral reconstruction.[47-49] In prospect of overcoming this issue, 
adhesive strategies have been utilised. Elisseeff and colleagues have achieved a 
stable bonding of biomaterials to native tissue by ‘painting on’ a aldehyde and 
methacrylate functionalised chondroitin sulphate layer.[50] Aldehyde will react with 
amines in the tissue via spontaneous Schiff-Base reaction. The methacrylate groups 
then allowed covalent links between tissue and biomaterial upon UV light exposure. 
Others, like Zhu and colleagues, have utilised naturally inspired catechols to achieve 
tissue adhesion, including cartilage.[51] Catechols, like 3,4- dihydroxyphenyl-L-
alanine (Dopa), are abundant in the mussel-foot proteins, allowing a range of different 
interactions.[52, 53] Dopa can be used to form cross-linking connections (Dopa-
Dopa) and therefore solidify a material, or react with inorganic and organic materials 
alike, which could enable cell or tissue interaction. Kim et.al. have used gelatine as a 
backbone construct and further modified it with methacrylate and Dopa moieties.[54] 
Hydrogels were prepared by mixing the macromer with iron-dichloride (FeCl2) as well 
as hydrogen peroxide (H2O2). The following Fenton reaction covalently cross-linked 
the methacrylate moieties and formed ionic interactions between Fe3+ ions and the 
reduced Dopa. They conclude that the material might have sufficient properties to be 
used as an injectable wound-dressing or other adhesive materials. Han and 
colleagues grafted a clay-polyacrylamide layer onto skin, with poly-dopamine as an 
adhesive layer.[55] The material shows rapid interaction with the host tissue, without 
resulting in an inflammatory response at the application site, confirming Dopa to be 
well tolerated by human tissues. Lee and team have modified poly-ethyleneglycols 
(PEGs) with Dopa.[56] They achieved cross-linking within several hours, by addition 
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of sodium periodate and horseradish peroxidase, or by mushroom tyrosinase.     
Others have utilised the Dopamine precursor tyrosine for adhesive purposes.[57, 58] 
Moreira Teixeira and colleagues have modified dextran and heparin with tyramine 
and filled cartilage defects with the resulting hydrogel.[57] Rapid enzymatic cross-
linking occurred within 1 - 2 minutes after mixing the hydrogel with horseradish 
peroxidase and H2O2. In this manner, tyramine of the hydrogel reacted with itself and 
thereby solidified, as well as bound covalently to the tyrosine residues in the 
surrounding host cartilage, enabling stable adhesion. Similarly, Cui and colleagues 
have modified silk with tyrosine, however, their system is cross-linked by visible light 
(400 - 450 nm) via ruthenium (Ru)/sodium persulfate (SPS) reaction.[58] Further 
incorporating gelatine into their system, the systems shows higher flexibility in its use 
as the time for application was more compliant. 
 
1.1.3 Hydrogels for tissue engineering 
Utilising hydrogel-based system for tissue engineering is a rather new approach in 
clinical applications and seem to have attracted researchers interest quickly.[59]          
Hydrogels are composed of chains of hydrophilic macromolecules which are able to 
retain vast quantities of water, reaching up to several thousand-fold weight 
increase.[60] This is lowered by factors like modification or polymeric immobilisation. 
Stable gels are formed from a precursor solution by cross-linking single molecules via 
kinetic chains. Physical properties can be easily influenced by changing molecular 
weight or amount of macromer, as well as varying molecular weight and density of 
the cross-linker. Depending on the reactive moieties present on the macromer, cross-
linking can be achieved in several ways. Most common are ionic, thermal, enzymatic, 
chemical and light cross-linking.[61] Chemical modification of such macromers is 
mostly easily achievable and once produced enables effortless and modular hydrogel 
fabrication, allowing versatile application. Those systems all have a strong focus on 
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biocompatibility. Here, cellular interactions are playing a key role. According to their 
surroundings, cells are highly capable of moulding and rearranging its pericellular 
space in order to maintain and thrive within their respective niche.                       
Therefore, degradability is a major factor to consider when designing a hydrogel 
system, resulting in by-products that can be easily removed via bodily functions.[62] 
Once successful population has been completed, cells actively remodel their 
surrounding and secret their own ECM.[63] This results in the hydrogel carrier being 
fully replaced over time with newly synthesised ECM, recapitulating structural and 
functional neo-tissue. Formation of such extracellular components is mostly 
determined in vitro by immunohistochemistry, whereby quantity and composition of 
newly formed matrix elements allows comparison to natural tissue. This enables 
selection of ideal compositions for further testing. Although such 
immunohistochemistry techniques allow high spatial resolution and precise 
identification of individual matrix components, they also remain expensive and time-
consuming methods, which request initial knowledge about the potential substances 
to be tested for. More recently developed techniques like non-canonical amino-acid 
tagging or Raman spectral imaging could be inexpensive and accessible tools to 
substitute immunohistochemistry for tissue engineering research. 
 
1.2 Temporomandibular Joint Disorders 
1.2.1 Anatomy of the Temporomandibular Joint 
The temporomandibular joints (TMJs) connect the lower jaw on both lateral ends to 
the rest of the skull (Figure 2). They are composed of an articular head and a 
mandibular eminence, which are bone tissues. Both are separated by the articular 
disc, a cartilage-like tissue. The articular surface of the condylar head itself is covered 
with a thin layer of fibro-cartilage. Overall, the joint is held together via fibrous 
capsules and several muscles. Processes like chewing, speaking or yawning require 
Christoph Salzlechner 
Page 24 of 152 
 
motion of the TMJ. The condylar head moves in an anterior direction when opening 
the mouth, by gliding on the articular disc along the mandibular eminence.            
Moving back in the posterior direction will close the mouth. 
 
Figure 2:Temporomandibular Joint. [64, modified] 
Two temporomandibular joints are connecting the lower jaw to the rest of the skull. 
They are fundamentally composed of a condylar head and a mandibular eminence, 
which are separated by an articular disc. Furthermore, the condylar head is covered 
in a fibrous-cartilage layer. 
 
Although several components can factor in, this project has focused on damages to 
the fibrous cartilage of the condylar head exclusively (as illustrated in Figure 2, right 
image). Fundamentally, the cartilage layer of the TMJ differs from other articular 
cartilage tissues. With approximately 0.5 mm in thickness, TMJ cartilage is amongst 
the thinnest chondrogenic layers in the human body.[65] This articular cartilage layer 
in the TMJ it is mainly comprised of fibrous cartilage. Structural composition is divided 
into 4 histologically distinct layers (Figure 3); the fibrous layer on top contains mainly 
type I collagen, with low quantities of type II collagen, hosting morphologically flat 
fibroblast-like cells.[66] The proliferative layer underneath is made purely of type I 
collagen and contains undifferentiated mesenchymal progenitor cells, which  function 
as a cell reservoir. Those progenitors have the potential to transition into type II 
collagen-synthesizing pre-hypertrophic chondrocytes.[67] Both of these layers have 
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parallel anterior-posterior alignment of ECM fibres, with chondroitin sulphate as the 
non-collagen matrix component. The thickest layer is made of actual fibrocartilage. 
This layer has a mature and a hypertrophic sheet, composed of type II collagen, as 
well as type I and X collagens, housing mature chondrocytes.[68] Here, collagens are 
aligned randomly, with aggrecan as an abundant matrix component.[69] Origin of the 
cellular content in the cartilage layer of TMJ remains unclear, however, reports 
suggest that initial formation of the TMJ osteochondral components is facilitated by 
neural crest cells and mandibular bone periosteum cells.[70] Recent studies have 
indicated that Wnt signalling and hypoxic oxygen conditions play crucial roles in 
terminally differentiating and maintaining homeostasis in TMJ chondrocytes.[71-74] 
 
Figure 3: Structural composition of TMJ articular cartilage. 
Black lines represent alignment of collagen fibres, with different cell types in purple. 
 
1.2.2 Clinical appearance of Temporomandibular Joint Disorders 
Damages to this joint are classified as Temporomandibular Joint Disorders (TMDs). 
Pathologically, TMDs are characterised as local deterioration of articular tissue, 
resulting in loss of function and high pain levels. Comparing to other osteochondral 
defects in the human body [2, 6, 9, 10, 75], TMDs appear in highly complex aetiology 
and are of multicausal origin.[76] There are three groups of factors influencing TMDs: 
predisposing factors (increasing the likelihood to develop a symptom of TMD), 
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initiating factors (causing the onset of TMD) and perpetuating factors (increasing the 
severity and progression of TMD as well as reducing the chances of successful 
treatment).[77, 78] Treating TMDs effectively relies on identifying all of the factors 
influencing the TMD in a particular patient.  Factors triggering TMDs include occlusal 
abnormalities, bruxism, orthodontic treatment and orthopaedic instability, trauma 
(macro/micro traumata), joint laxity, hormonal imbalance (exogenous oestrogen), 
cancer, other degenerative diseases, malnutrition, stress, mental tension as well as 
anxiety and depression.[77, 78] Although not causative, inflammatory responses     
(i.e. osteoarthritis) seem to be a major driving aspect of TMDs.[45]  
Clinically, TMD progression is classified in 5 stages, which are characterised via 
assessment of joint mobility and imaging techniques.[79] Stage 1 most often presents 
clicking sound of the joint, with no to low pain levels during jaw motion. In stage 2, 
sporadic pain occurs together with recurrent jaw locking and headache.                   
Stage 3 shows advanced symptoms from stage 2, together with painful chewing and 
restricted range of joint motion. Imaging often reveals disc displacement.[80, 81] 
Following, stage 4 presents chronic mild to severe pain to joint and general headache 
with severely restricted jaw motion. When imaged, the disc often appears thickened, 
with abnormal contours of condylar head as well as mandibular eminence.        
Patients in stage 5 experience constant pain, with strong structural and functional 
deterioration of disk as well as mandibular and condylar surface.  
Approximately 30% of Europeans will suffer from TMD at one point during their life 
[78], with the greatest risk of onset between 18 and 44 years of age.[82] It is estimated 
for every 100 million working adults in the United States, TMD contributes to             
17.8 million lost working days.[83] More than 80% of these patients will recover with 
non-surgical conservative management. Such conservative treatments include 
immobilisation and rest, non-steroidal anti-inflammatory drugs (NSAIDs), behavioural 
therapy, pain management and bite splints.[78, 84] Unlike in the field of orthopaedics, 
Christoph Salzlechner 
Page 27 of 152 
 
where a wide range of techniques are available to treat bone or cartilage disorders 
[2], maxillofacial surgeons are limited with their options. Often it is more a palliative 
approach rather than a curative treatment. Patients with refractory TMD and 
persistent pain as well as limitation of function along with structural pathology of the 
TMJ, are considered for surgical intervention. Surgical procedures range from intra-
articular injections, to minimally invasive arthrocentesis and arthroscopy [85] through 
to open joint procedures.[78] Open TMJ surgeries includes disc surgeries, like 
discectomy and plication, as well as surgery on the bony elements of the TMJ, such 
as an eminectomy, high condylar shave or condyloplasty.[86] In the most severe 
cases, an alloplastic joint replacement is recommended. The process of open joint 
surgery can be destructive, has high risk of causing damage to the facial nerve, 
leaves scares in the facial area and requires long healing periods.[87] 
 
1.2.3 Tissue engineering for TMDs 
Compared to other regenerative approaches for osteochondral tissues (see 1.1), very 
few groups are focused on exploiting tissue engineering for TMJ repair. This is likely 
for a number of reasons such as the small size of the condyle and complex surgical 
access to it as well as a small group of patients suffering from TMDs. These reasons 
are also limiting the applicability of TE-techniques developed for other joints to be 
used in TMJ reconstruction. Furthermore, there is a lack of appropriate in vivo models 
available due to vast differences in structural and functional performance of the TMJ 
in various species. Comparing numerous species,  minipigs are considered to be gold 
standard for a large animal TMJ model, established on similarities to the human 
anatomy, size as well as mechanical load and function.[88, 89] The use of other 
models could limit the clinical significance for human subjects. Adding to this, TMJ 
surgery perhaps inflicts significant reduction in jaw movement or complete immobility, 
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which might not allow the animal to feed and therefore cannot be considered ethically 
compliant. Altogether, this is restricting the ability to produce conclusive data.[90]  
Accordingly, the existing published information is limited. For example, Zhu and 
colleagues [91] overexpressed NELL-1 (NEL-like molecule-1) in goat autologous 
bone marrow-derived mesenchymal stem cells (BM-MSCs) and incorporated them in 
a poly lactic-co-glycolic acid (PLGA) scaffold. They placed the solid scaffolds in critical 
size defects (CSD) of goat mandibular condyle. After 6 weeks, histological analysis 
showed bone and cartilage formation, which they concluded as successful recovery. 
However, PLGA degradation forms acidic side products which may contribute to bone 
decalcification. In summary, they showed short term structural recovery but do not 
analyse the functional recovery of the specimen. Further research has been done on 
cell-free tissue engineered approaches embedding soluble growth factors like 
fibroblast growth factor-2 [17] and bone morphogenetic protein-2 [16]. Although they 
have proven the stimulation of ECM secretion by present chondrocytes, this requires 
further testing for human applications. Wang and colleagues have further investigated 
cell types to promote optimal TMJ cartilage regeneration.[92] They have found that 
chondrocytes harvested from porcine hyaline cartilage produced significantly more 
ECM in vitro then  those sourced from porcine TMJ cartilage. Besides low volume of 
TMJ cartilage, and therefore small quantities of cells available, chondrocytes 
harvested from other non-loadbearing cartilage might be a superior approach in TMJ 
fibro-cartilage regeneration. Considering that this approach would require another 
surgical intervention, extended time to process the cell material and chondrocytes 
harvested could lose their phenotype, mesenchymal stem cells delivered via 
microfracturing might overcome those concerns.   
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1.3 Project design and scope 
Considering the literature available (see 1.1 page 15 following, and 1.2 page 23 
following), this project has been targeted specifically for towards arthroscopic TMJ 
surgery. Subsequently, justification and critical analysis of the overall project design 
is stated, with specific aims summarised in 1.3.5 (page 41). 
In order to comply with the complex structure and accessibility of TMJs, hydrogels 
have been utilised for this project. They bare the capacity to be applied in 
liquid/viscous form on site and therefore have the potential to be used in minimal 
invasive techniques. Such arthroscopic approaches would be favourable for TMJ 
surgeries, considering that solid materials would require destructive open-joint 
techniques (see 1.3.1, page 29). The hydrogels should further be able to support cell 
attachment and tissue adhesion. 
 
1.3.1 Minimally invasive approaches 
Arthroscopic surgeries in the TMJ have been performed for over 40 years.[93]           
The double puncture technique has allowed access to the TMJ to enable the use of 
laser [94], motorized shaver [95] and disc repositioning. Nevertheless, there is 
currently no option available to introduce a material which enables regeneration of 
the damaged tissue in a minimal invasive fashion. Some clinicians argue that 
arthroscopic techniques require more time during which the patient is sedated and 
involve special equipment and training. Although, the stress and discomfort patients 
experience from an open surgery as well as the long recovery period and possibility 
of pathological scar formation, suggest that minimally invasive procedures should be 
favoured.  This is supported by evidence that pain and psychological factors play a 
key role in successful treatment courses.[96] These have the potential to be reduced 
with minimally invasive treatments. Furthermore, damages to the facial nerve can be 
reduced drastically with minimally invasive approaches. As such, arthroscopic 
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surgery is the superior technique with the reduction in complications, however, 
restoring damaged TMJ articular surfaces by delivering factors that stimulate 
endogenous repair remain unidentified. 
Restoring the fibro-cartilage of the condylar head requires several specifications 
towards such a procedure. The proposed arthroscopic technique is summarised in 
Figure 4. Here, the damaged TMJ cartilage would be removed, an injectable hydrogel 
material (with/without cells and biologically active factors) would be applied and 
solidify upon dental blue light exposure. 
 
Figure 4: Proposed arthroscopic approach to repair fibrocartilage of condylar head in 
TMJ. 
Damaged fibrous-cartilage is removed via drill or laser and debris is flushed out. 
Afterwards the defect side can be filled with the hydrogel solution, carrying cells 
and/or drugs. The solution can be moulded and solidified upon blue light stimulus. 
 
Several key-factors have to be considered for the further design of a hydrogel to be 
used in such arthroscopic TMJ surgery.  Firstly, the joint space is inflated with liquid. 
This has several benefits for the surgeon like cooling during abrasive processes, 
removal of floating debris to improve vision as well as increasing space for handling. 
Therefore, materials need to be applicable under aqueous conditions and solidify 
quickly upon exposure to a triggering stimulus (i.e. visible dental light). This allows 
the surgeons to apply, mould or simply remove and reapply the material if necessary, 
without a limited reaction window to do so. Secondly, the material needs to be 
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injectable via a syringe system. The application of a material can be troublesome, as 
the space is confined, so it should be easy to mould or remove, in case it needs to be 
re-applied. Viscosity is a crucial property here, as it should not dissolve in the liquid 
surrounding but should also be applicable via a syringe. Thirdly, possibility for 
preparing materials within an operating theatre is limited and ideally should be done 
before the surgery is starting. This makes shelf-life an important factor to be 
considered. 
 
1.3.2 Advantages of methacrylated HA-hydrogel system 
Choosing a backbone for the design of a hydrogel leaves one with a vast range of 
different materials available. However, hyaluronic acid (HA) is a material used on daily 
basis in clinics, showing high tolerance in patients across different physiological 
background, with less than 2 % of patients experiencing adverse effects like rash, 
nausea or muscle cramps.[97, 98] HA is a hydrophilic linear polysaccharide 
composed of repeating disaccharide units of N-acetylglucosamine and D-glucuronic 
acid. It is an integral part of most human tissues, including cartilage.[99]          
Moreover, the utilisation of hyaluronic acid in the TMJ is well documented and there 
is some evidence that it may positively influence inflammatory mediators in the 
osteoarthritic  process.[100, 101] Unmodified HA could also be applied to increase 
the overall viscosity of a hydrogel-precursor solution, without drastically influencing 
the resulting cross-linking behaviour of the modified HA. In addition, the physical 
properties of HA-hydrogel scaffolds, such as stiffness, degradability and swelling play 
important roles in directing the differentiation of the encapsulated cells.[102, 103] 
Soluble factors as well as physical attributes of the extracellular scene are known to 
direct lineage specification.[104] Stem cells encapsulated in hydrogels have the 
ability to probe their surrounding stiffness and influence their fate by degrading that 
same hydrogel.[105, 106] More recently, Ferreira and colleagues have shown that 
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stem cells have the ability to swiftly remodel their surroundings to their needs by 
degrading and replacing HA-based hydrogels with their own matrix.[63]                     
Here, stiffness can be influenced by the amount of modified HA macromere or degree 
of macromere modification. They directly correlate with other physical properties as 
an increase in those components would lead to reduced swelling and degradation 
behaviour. Consequently, hydrogels are supposed to be structurally stable but still 
remain degradable for cells. In addition, swelling is occurring due to the hydrophilic 
nature of HA, providing a microenvironment that facilitates delivery of nutrients, 
oxygen and the necessary growth factors to the encapsulated cells.[60, 107]             
This effect should occur rapidly within a few hours, to ensure cells are sufficiently 
supplied with necessary metabolites. 
In order to cross-link HA into a solid polymeric network, members of the acrylate 
family are one of the most utilised modifications.[108-113] There are two common 
ways of triggering a polymerisation reaction with an acrylate, one is a redox reaction 
via thiols (Michael-addition reaction)[114], another one is light induced reaction. 
Michael-addition reactions occur spontaneously, which can be troublesome for 
clinical application as this is limiting to the application window. Light-induced reactions 
on the other hand, can be triggered in a controlled fashion. This reaction can be 
achieved by a radical source, i.e. Irgacure 2595, which emits a radical upon UV light 
exposure. This radical can attack the alkene group on an acrylate, which itself can 
lead to a covalent bonding with another nearby acrylate. Although frequently used for 
research purposes, UV light has raised doubts about its clinical safety, as it can lead 
to oxidative stress or DNA strand breaks in vital cells, resulting in uncontrolled 
mutations in those cells affected.[115] Here, clinical manifestation of UV mutagenic 
effects have been extensively investigated for melanoma skin cancer, where the UV 
portion of the sun light has been shown to have the potential of trigging several 
mutagenic changes. Relating to photochemical light exposure used for TE, Ruskowitz 
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and colleagues have shown that near-UV exposure at 365 nm wavelength has no 
effect on hMSC proliferation, compared to middle-UV light at 254 nm wavelength, 
where hMSCs were statistically significantly reduced in proliferation.[116]                  
This indicates, that higher wavelengths (i.e. visible blue light at >400 nm) might be 
better tolerated by cells. A shift towards higher wavelengths as activator has been 
done in dental components. Dental composites, fillers and glues are often acrylate 
based with camphorquinone  as photo-initiator, and can be solidified quickly upon 
exposure to blue light (dental light, 400 - 500 nm wavelength).[117-119]  
In order to translate that into an acrylated hydrogel system, novel photo-initiator 
molecules with good water solubility are required. As promising candidate, Eosin-Y is 
classified as a visible-light-sensitive photo-initiator, that following excitation with blue 
light (low frequency band of visibility) can undergo a transition to a triplet state. In this 
triplet state, one electron is excited to a higher energy level in which it is reactive 
towards reducing components such as thiolated molecules, transitioning Eosin-Y 
from red to yellow (Figure 5, top).[120, 121] The created thyil radical then initiates a 
step-growth photo-polymerisation reaction with the carbon-carbon alkene of the 
acrylate group, leading to a solidified hydrogel (Figure 5, box). Using low molecular-
weight (=short) dithiolated molecules like DTT might limit the cross-linking efficacy. 
Whereby high molecular-weight molecules (=long) like dithiolated PEG have the 
potential to interact with moieties in further proximity during the second polymerisation 
step. 
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Figure 5: Eosin-Y photo-polymerisation system and thiol-ene cross-link formation. 
(Top) Schematic representation of radical generation reactions of HS-PEG-SH 
initiated by photo-induced activation of Eosin-Y. Eosin-Y can be excited upon visible 
light exposure to a higher energy level in which it is reactive towards reducing 
components such as thiolated molecules. (box) Polymerisation mechanism for 
visible-light-mediated thiol-ene photo-polymerisation. The created thyil radical 
initiates a dual step-growth polymerisation reaction with the carbon-carbon alkene. 
Other thiolated molecules (i.e. DTT) follow the same mechanism. 
 
Synthesising acrylated macromers usually involves chlorinated solvents.[108, 122-
124] Although traces of it might be considered safe for use in other parts of the body, 
the sensitivity of maxillofacial tissues to toxins leached from biomaterials has been 
described by Renard and colleagues.[125] This is critical as the facial nerve and 
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central nervous system are in close proximity to the TMJ. Such cases have made 
clinicians highly cautious when it comes to using biomaterials in maxillofacial 
therapies. Chlorinated solvents, particularly trichloroethylene (TCE), 
perchloroethylene (PERC) and dichloromethane (DCM), have been associated with 
general neurological toxicity.[126] Indeed, exposure to dichloromethane has been 
directly linked to facial nerve palsy, which is an important concern, particularly in TMJ 
application, which is in immediate surrounding of the facial nerve.[127] Even though 
modern processing techniques might be able to remove these solvents to a clinical 
grade, avoiding the use of such would eliminate any risk of toxicity and exclude 
suspicions of clinical end users. Consequently, the synthesis process for this project 
was designed completely solvent free, creating methacrylated hyaluronic acid        
(MA-HA) (see 2.2.1). 
 
1.3.3 Importance of dopamination in MA-HA-hydrogel system 
Hyaluronic acid as part of the ECM promotes cellular interactions via several 
transmembrane receptors like CD44 and RHAMM, which have been linked to cell 
survival and maintaining vital chondrocytes.[128, 129] However, HA is missing 
integrin binding-sites, which are required for migration and accumulation of cells. 
Furthermore, HA is lacking capability to adhere to the surrounding tissue. 
Classical adhesive agents to foster tissue interaction are mainly based on synthetic           
(i.e. poly-cyanoacrylate [130], carbodiimide- or genipin-cross-linked gelatine [131]) or 
natural polymers (i.e. gelatine–N-hydroxysuccinimideactivated poly-L-glutamic acid 
[132], azide–lactose-modified chitosan [133], fibrin glue [134, 135]). However, those 
have none to limited application in arthroscopic procedures in the TMJ, as they either 
release cytotoxic components when degraded, require human-sourced products or 
would be unpractical for the type of surgery employed here. A more promising 
technique described by Elisseeff and colleagues[50] is based on research initially 
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done by Ono and colleagues[133]. Although improved, it is lacking applicability in 
arthroscopic approaches in the TMJ, as the ‘painted on’ chondroitin sulphate would 
be washed away in an aqueous inflated joint space before adhesion could take place.  
As further described in 1.1.2, catechol modified hydrogels have shown promising 
results to overcome this limitation. Such catechols are naturally inspired by mussels, 
which have the ability to adhere strongly to organic as well as inorganic materials in 
marine saltwater environment. From the six identified mussel-foot proteins (Mfps) 
known so far, adhesion is caused by Mfp3 and Mfp5, which are abundant in the 
terminal ends of byssal threads.[53, 136] The adhesion effect is given by 3,4-
dihydroxyphenyl-L-alanine (Dopa), an amino acid that represents up to 30 mol% of 
Mfp-5.[136]  
This unique feature is caused by a catechol side group within the Dopa, which is 
capable of a dual chemistry to form reversible covalent or irreversible non-covalent 
interactions (see Figure 6).[52] In tissue engineering, catechol chemistry has been 
sourced for several of its properties. The dihydroxy functionality of catechol is capable 
of forming strong non-covalent hydrogen bonds with hydroxyapatite (Figure 6A), while 
the benzene ring of the catechol enables it to interact with aromatic rings and 
positively charged ions, found in the components of ECM, through 𝜋 − 𝜋 and cation-
𝜋 interactions (Figure 6B-C), respectively. This allows the material to interact with 
bone, glass and metals (Figure 6E). Some groups also utilise Dopa to cross-link 
hydrogel systems. This can be done via iron-ion-particles [137, 138] (Figure 6D) or 
by actively oxidising Dopa moieties [56, 139, 140] (Figure 6H-I). Oxidising Dopa forms 
semi-quinone or quinone states, in which Dopa is either reactive towards each other 
or interacts with nucleophilic moieties like amides (–NH2) and thiols (–SH), which are 
found in proteins (Figure 6J). Thereby, Dopa performs interaction to either soluble 
proteins, which would allow integrin-mediated cell attachment, or tissue bound 
proteins, which would allow tissue interaction.  
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Figure 6: Non-covalent (blue) and covalent (green) interactions of Dopa catechol. 
([52], modified) 
In its reduced form catechols can interact non-covalently via: hydrogen bonds with its 
OH groups (A), π–π electron interactions with benzene rings (B), cation–π 
interactions with positively charged ions (C), chelates metal ions (D) and forms co‐
ordination bonds with metal oxide surfaces (E). In its oxidised state, Dopa creates 
semiquinone and quinone forms, which facilitate covalent interactions (F and G). 
Quinones can polymerise with each either by tautomersiation via quinonemethide and 
α,β‐dehydrodopa formation (H) or by directly forming dimers with another catechol 
moiety (I). Quinones also react with various nucleophiles (i.e., –NH2, –SH) found in 
proteins, which can lead to tissue adhesion (J). 
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In neutral pH range, catechols are usually fluctuating between (semi-)oxidised and 
reduced state. Consequently, acidic pH would tilt this balance towards a more 
reduced equilibrium (non-covalent interactions), basic pH towards an oxidised 
equilibrium (covalent interactions). pH therefore plays a crucial role during synthesis 
and storage. When applied bound to a hydrogel-network in an in vivo system, Dopa 
might be locked in the oxidised state, when it reacts with proteins and peptides alike. 
As this reaction is covalent, the Dopa may not be able to fall back into its reduced 
state. This effect is referred to here as auto-oxidation. A similar effect can be reached 
by using oxidising agents like sodium periodate.[54-56] However, such agents might 
be hard to apply within the liquid surrounding of an arthroscopic TMJ surgery and 
would limit the time window to apply the construct. Considering this, auto-oxidation of 
Dopa might be favourable for such a clinical approach. 
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1.3.4 Evaluating cellular matrix secretion within 3D hydrogels 
Tissue-forming ability of regenerative materials is often assessed by the amount of 
matrix produced and secreted by cells present. Recent studies have shown that 
human mesenchymal stromal cells 3D-encapsulated within hydrogels have the ability 
to swiftly modify their local surroundings. They do so by degrading the hydrogel and 
replacing it with secreted proteins within their immediate pericellular space.[141-143] 
Consequently, techniques to characterise and visualise secreted pericellular matrix 
within hydrogels are essential to compare cellular behaviour, exposed to different 
chemical and physical conditions. Ultimately, this is crucial to evaluate potential 
regenerative therapies. 
As gold-standard, immunostaining methods allow to visualise the location of specific 
proteins within tissues and hydrogels.[144] Still, in order to choose appropriate 
antibodies, such techniques require prior knowledge of the proteins targeted.                  
In addition, these methods are time-consuming and expensive. Therefore, initial 
knowledge of potential composition of this secreted matrix might allow a limitation of 
the vast range of antibodies to choose from, which ultimately could reduce overall 
effort needed for immunostaining methods. Other approaches like mass spectrometry 
are utilised for various proteomics techniques, which are capable of identifying 
proteins within a sample.[145] Although a powerful tool, proteomics often lacks 
positional information. More advanced techniques combine desorption electrospray 
ionisation (DESI) with mass spectrometry[146] and emerging single cell proteomics 
techniques[147]. Such applications would overcome the limitation of missing special 
information, however, these approaches require highly specialised equipment and 
remain too expensive for high-throughput purposes. Hence, novel systems or a 
combination of already existing techniques, that are inexpensive, accessible and can 
provide information about the distribution and composition of the secreted matrix are 
desirable. 
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Fluorescent non-canonical amino acid tagging (FUNCAT), is based on the principle 
of replacing a canonical amino acid in cell culture medium with an analogue 
containing a bio-orthogonal functional group to which a fluorophore can be 
“clicked”[148]. FUNCAT is available as highly reliable and cost-effective kits. 
FUNCAT allows for 3D visualisation of proteins that have been translated whilst 
cultured with the amino acid analogue, allowing spatial imaging of the secreted matrix 
with minimal further manipulation. FUNCAT is used by several groups to investigate 
pericellular matrix formation.[63, 141, 143] 
Raman spectroscopy is based on the inelastic scattering of monochromatic light that 
has been used to identify the biochemical composition of single cells[149], as well as 
tissues[150, 151] and matrix formed by cells in vitro[152-155]. Raman spectroscopy 
does not require additional staining methods and has the power to distinguish 
between biologics like proteins, lipids, and nucleic acids. Furthermore, it is 
inexpensive and accessible to many research facilities. 
Combining FUNCAT with Raman spectral imaging, would allow to create 3D spectral 
and fluorescence maps of hMSC and their secreted matrix when encapsulated within 
hydrogels. Both techniques are simple, unbiased, inexpensive methods that require 
little manipulation and permit imaging without the need for sample sectioning.              
As such, the combination of both approaches should provide enough information to 
assess the effect of different hydrogel compositions and DMOG upon hMSCs ability 
to secret matrix. Quantitative and qualitative analysis can be done by signal intensity 
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1.3.5 Aims of thesis 
Considering different TE tactics available, a combined cell-material strategy has been 
approached for this project. Subsequently, double-modifying HA with methacrylate as 
well as Dopa may present several beneficial effects for minimal invasive application 
in TMJ surgery. The macromer is synthesised avoiding potentially harmful reagents. 
It can be applied via syringe and withstands an aqueous environment similar to that 
during arthroscopic TMJ procedures. Furthermore, application and solidification does 
not require special training or equipment. As it is photo-polymerised, the material 
remains viscous and can be manipulated until light is applied. Eosin-Y also functions 
as an indicator, as it changes colour during the polymerisation process. Dopa as 
biological functional group, will oxidise without addition of reagents, decorating itself 
with soluble proteins and interact with neighbouring proteins within tissues. 
 
Figure 7: Schematic showing application, formation and oxidation of MA-HA-Dopa 
hydrogel. 
Upon blue light exposure, Eosin-Y deprotonates di-thiol PEG, allowing it to react with 
methacrylate moieties on HA leading to a formation of kinetic chains. This process 
reduces Eosin-Y to a colourless state. Following Dopa oxidation impacts protein, cell 
and tissue interactions with hydrogels. This coincides with a characteristic brownish 
change of colour of the catechol groups. 
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Concluding therefrom, specific aims for this project cover the following: 
A) Development and characterisation of MA-HA-Dopa hydrogels. 
Aa) Synthesise double-modified HA-macromers with MA and Dopa moieties. 
Synthesis is going to be established for double-modified MA-HA-Dopa 
macromers using a fully aqueous reaction protocol. Furthermore, the 
modification reaction will be optimised to achieve reproducible degrees of 
modification (DOMs) by investigating several buffers as well as manual pH 
adaption during the methacrylation process. Ensuring the dopamine is 
maintained in its reduced form is central because under basic conditions, the 
catechol functional group can form a semi-quinone or quinone.[156] Quinone 
is highly reactive and can form dimers with other catechols, potentially cross-
linking MA-HA-Dopa macromeres prematurely during the synthesis 
process.[157] Varying the conditions for those reactions, a range of HA-
macromers with total DOMs from 0 to 50 % will be produced.         
Confirmation of successful modification and determination of DOM is going 
to be performed with 1NMR. 
Ab) Characterise hydrogels for mechanical and physical properties. 
A range of mechanical, physical and chemical properties can be limiting for 
the use in arthroscopic approaches in the TMJ.  
• Viscosity has to be tailored to a certain range for optimal use in 
arthroscopic approaches. Addition of unmodified 1 MDa HA is expected to 
increase viscosity of MA-HA and MA-HA-Dopa precursor solutions 
significantly. Viscosities reached are supposed to be in a range of 10 to 
20 Pa·s, which is similar to commercially available dental materials.[158] 
Gelation kinetics and bulk stiffness are going to be assessed via time-
sweep rheology. Clinically relevant materials are required to solidify 
rapidly within <4 minutes exposure to standard clinical blue light. Shelf-life 
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is an important factor here as well. Precursor solutions are expected to 
reach similar bulk stiffnesses after being stored for longer than 24 hours. 
Here, RT as well as 4 ˚C (fridge) storage temperatures are investigated, 
reflecting potentially necessary conditions for when cyto-active 
components are incorporated into the precursor solution. 
• Mass swelling and degradation are critical factors for evaluating 
hydrogels. Swelling and degradation are reflecting a behaviour of the bulk 
gel by liquid influx and the following degradation of the matrix due to 
cellular (i.e. enzymes) and mechanical influence (i.e. shear forces). 
Swelling is going to be assessed gravimetrically by determining the 
increase in wet-weight of the bulk hydrogels over time. Following, 
enzymatic degradation via hyaluronidase is going to be quantified by 
carbazole assay. Here, HA degradation products are detected in the gel-
surrounding fluid by colorimetric changes using photometry. 
• Oxidising Dopa moieties should facilitate cell and tissue interaction.             
In order to allow a certain time-frame for application, Dopa should self-
oxidise after several hours. Oxidation is going to be determined 
qualitatively by characteristic colour change to brown. This will further be 
proven quantitatively over time by creating photometric absorption profiles 
of MA-HA-Dopa macromers. Oxidised catechols are supposed to have 
increased light absorption in a range between 250 to 450 nm wavelength. 
Comparing normoxic and hypoxic conditions is investigating catechol 
behaviour under cartilage-specific oxygen levels.  
Ac) Optimisation for clinical use 
Feedback on the surgical approach and material properties are given by 
maxillofacial surgeons, dentists and ENT specialists. This includes constant 
input during the material development. Combined with literature accessible 
on conventionally available materials, this should maximise the potential for 
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clinical translation. The effort is focused mainly on the synthesis (potential 
hazardous components, current use of materials in clinics; see (Aa), page 
42) as well as the mechanical and physical characteristics (viscosity, gelation 
behaviour, preparation and storage, as well as material handling; see (Ab), 
page 42). 
B) Cell and tissue interaction 
Ba) Cytotoxicity and 3D cell survival 
Firstly, all components of the hydrogel are required to be fully tolerated by 
human cells, showing no cytotoxic effect. Cytotoxicity is a key characteristic 
to be considered and is regulated by ISO 10993-1.[159] A range of 
concentrations of those components shall be tested via MTT assay to 
confirm absence of any toxicity. Secondly, the encapsulation of primary 
human cells is supposed to support cell survival, which considers 
mechanical forces (shear forces during mixing with hydrogel solution and 
application through needle) as well as physical forces (irradiation with blue 
light and potential local increase in temperature). Cell survival is going to be 
determined by L/D staining. 
Bb) 2D cell attachment 
Cell attachment could allow cell infiltration, which might sustain techniques 
like micro-fracturing. Stable cellular interaction (i.e. via integrins) with         
MA-HA-Dopa hydrogel will be proven via 2D attachment experiments.   
During a short incubation time, Dopa can bind soluble proteins, which further 
allow cell interaction with the hydrogel. Hydrogel formulations lacking Dopa 
moieties cannot support such stable interactions resulting in cells being 
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Bc) Tissue adhesion 
Interaction with surrounding host tissue might permit the hydrogel to 
withstand external forces and could facilitate adhesion of the neo-tissue 
formed. Similarly as for the cell attachment experiments, oxidised Dopa will 
interact with proteins in the tissue available. This effect shall be shown 
qualitatively by application of force to a tissue-hydrogel interface. Catechol-
mediated adhesion is supposed to allow a transition of the displacement to 
the hydrogel, without rupture of the interface. Quantitative assessment is 
going to be performed via push-out tests. Hydrogels will be applied within a 
tissue biopsy. The weight necessary to push them out is going to be recorded 
and translated into force. Dopamination is supposed to statistically 
significantly increase the force necessary to drive the hydrogel out of the 
native tissue. 
C) Intra- and extracellular matrix formation 
In order to structurally and functionally restore tissue, cells have to produce and 
secret matrix components. This goes hand in hand with the degradation of the 
hydrogel matrix. Primary human mesenchymal stem cells from bone-marrow 
aspirates are going to mimic cellular behaviour  (i.e. sourced via microfracturing). 
Therefore, these cells will be encapsulated in different MA-HA-Dopa hydrogels 
and their ECM production shall be analysed via the following techniques: 
Ca) Non-canonical amino-acid tagging will report distance of newly synthesised 
proteins from the cell membrane.[160] This technique will allow to draw 
conclusions about cellular behaviour (production of proteinaceous content 
intracellular and extracellular) as well as about hydrogel behaviour in an in 
vitro setting (pore size and potentially degradability). Protein production and 
distance of secretion from cellular membrane is going to be compared 
between different hydrogel compositions. 
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Cb) Raman spectroscopy is going to be utilised to analyse cellular and 
extracellular components and resolve them for their chemical structure.         
In line with data from non-canonical amino-acid tagging, this should 
investigate the differences of protein production between various hydrogel 
compositions. Work with the Raman set-up is going to be performed by 
collaborating PhD student Anders Runge Walther (University of Southern 
Denmark). Credit for experimental execution and data analysis goes to him.  
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2 Materials & Methods 
2.1 Materials and equipment 
Unless otherwise stated, chemicals purchased were all of analytical grade.      
Materials used for cell culture were either purchased sterile or sterile filtered using a 
0.22 μm syringe filter. 





Manufacturer; Country of 
Origin 
1,4-dithiothreitol DTT Sigma-Aldrich 
2′,4′,5′,7′-
Tetrabromofluorescein 





Anti-biotic/anti-mycotic solution ABAM Gibco Life Technologies 
Borosilicate cylindrical glass 
moulds, 4 mm inner diameter 
 SciQuip Ltd 
Carbazole  Sigma-Aldrich 
D-glucuronic acid sodium salt 
monohydrate 
 Sigma-Aldrich 
Dopamine hydrochloride  Sigma-Aldrich 
high molecular weight 
hyaluronic acid sodium salt (1 
MDa) 
HA (1 MDa) Sigma-Aldrich 
hyaluronic acid sodium salt 
HA; 100 - 150 kDa; 
1 g per batch 
LifeCore Biomedical; 
Chaska, USA 
hyaluronidase (HAse, type I-S, 





glycol) (1 kDa) 
PEG; 1 g JenKem Technology 
Magnesium Fluoride slides MgF2 slides Crystran Ltd., Dorset, UK 
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N-hydroxysuccinimide NHS Sigma-Aldrich 





Table 2: List of equipment used 
Equipment Specification 
Manufacturer; Country of 
Origin 
532 nm laser Torus 532 
Laser Quantum, 
Stockport, UK 
Bruker Avance NMR 
spectrometer 
400 MHz Bruker 




CLARIOstar 430-0768  BMG Labtech 
Confocal laser scanning 
microscope 
DM16000 Leica 
Dichroic mirror  Semrock 
Fiber collimator  Thorlabs Inc., Ely, UK 
Fiber coupler 
50 µm core, low OH 
optical fiber 
Thorlabs Inc., Ely, UK 





Andor, Belfast, UK 
Laser fibre 






 Global Optics UK 
OmniCure light system 
S1500 
 Lumen Dynamics 
QHL75 dental curing light  Dentsply 
Thermomixer  Eppendorf 
Water immersion 
objective 
60x/1.0NA, CFI Apo NIR 
60X W 
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Manufacturer; Country of 
Origin 
17IA4 cell line mouse dental pulp cells  
Alpha MEM medium #BE0-002F Lonza 
Click-iT™ HPG Alexa 
Fluor™ 594 Protein 




glucose, no glutamine, no 
phenol red 
Gibco Life Technologies 
Fibronectin From bovine plasma Sigma-Aldrich 
Foetal bovine serum FBS; heat inactivated Gibco Life Technologies 
hMSC (also: hMSC) 
Human primary bone 
marrow aspirate 
 
HCS CellMask blue 
staining 
#H32720 Invitrogen 
MEM Alpha medium #41061-029 Gibco Life Technologies 
Recombinant human 
fibroblast growth-factor 
rhFGF; 175 aa R&D Systems 
Insulin-Transferrin-
Selenium-solution 
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2.2 Development and characterisation of MA-HA-Dopa hydrogels 
2.2.1 MA-HA and MA-HA-Dopa macromer synthesis 
MA-HA-Dopa was synthesised using two sequential reactions. For MA-HA, the 
second synthesis step was omitted, and the protocol followed from dialysis onwards. 
The methacrylation reaction (MA-HA) was adapted from previous reports (see     
Figure 8).[124] Briefly, HA (100 – 150 kDa) was reacted with a 20-fold excess of 
methacrylic anhydride relative to primary HA hydroxyl groups in an aqueous 
environment (pH 8). The pH was monitored continuously for 4 h at room temperature 
(RT) and adjusted by addition of NaOH, every 20 minutes. The reaction was then 
allowed to proceed for a further 20 h at 4 ˚C. Degree of modification was controlled 
by varying the amount of methacrylic anhydride (1:1 to 1:3, HA to methacrylic 
anhydride). HA was precipitated with ice-cold ethanol (5-fold excess) and the solution 
incubated on a tube roller for 10 minutes at RT. Precipitated HA was spun down at 
2,025 g for 15 minutes and the resultant pellet washed excessively with ice-cold 
ethanol. MA-HA was dried under vacuum and resuspended in dH2O (pH 5). 
 
Figure 8: MA-HA synthesis. 
Synthesis of MA-HA macromers through reaction of HA with methacrylic anhydride 
at a basic pH 8. 
 
The degree of methacrylation was confirmed by proton NMR and defined as the 
number of substituents per 100 hydroxyl groups in HA. This was determined by 
integrating the signals at δ 5.68 and 6.13 ppm (C=CH2 of the conjugated 
methacrylate) and comparing to the peak at δ 2.1 ppm (C(=O)CH3 in HA).  
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The dopamination reaction (MA-HA-Dopa) was carried out using a modified protocol 
to that reported previously (see Figure 9).[161] Briefly, MA-HA was dopaminated via 
a carbodiimide coupling reaction using EDC/NHS. The degree of dopamination was 
controlled by varying the MA-HA dopamine hydrochloride ratio from 1:0.5 to 1:2 and 
was allowed to proceed for 4 h (pH 5) in the dark. The double-modified macromer 
was purified via dialysis using 3.5 kDa MWCO tubing in acidic buffer (pH 5, HCl) for 
48 h, followed by dH2O for 24 h. Buffers were replaced twice a day. The final product 
was lyophilized and stored at -20 ˚C, protected from light. 
 
Figure 9: MA-HA-Dopa synthesis. 
Synthesis of MA-HA-Dopa macromers through EDC/NHS facilitated reaction of MA-
HA with dopamine at an acidic pH 5. 
 
The degree of dopamination was analysed by proton NMR to confirm the presence 
of characteristic peaks of catechol at δ 6.5 - 7.2 ppm, which correspond to the ortho 
and meta coupling position of the ring. The degree of dopamination was defined as 
the number of substituents per 100 carboxyl groups in HA and determined by 
integrating the signals at δ 6.5 - 7.2 ppm compared to that of the peak at δ 2.1 ppm 
(C(=O)CH3 in HA). 
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MA-HA reaction is strongly pH dependent, whereby the driving force is a basic pH. 
The amount of MA moieties bound to HA is thereby determined by the total amount 
of excess hydroxyl radicals provided throughout the overall reaction time of 24 h. 
During the binding process, those free radicals are exhausted, returning the pH 
towards neutral. As shown in Figure 10, the reaction is based on an acyl substitution 
mechanism. Hereby, the nucleophilic hydroxyl group of HA targets a carbonyl group 
of methacrylic anhydride. The subsequent deprotonation of methacrylic anhydride 
leads to a collapse of this intermediate state. This results in one part of the methacrylic 
anhydride being linked to the former hydroxyl group of the HA macromer.                      
The availability and amount of free hydroxide is driving the reaction forward, directly 
influencing the resulting DOM. Subsequently, performing this reaction step under 
controlled alkaline conditions is critical. pH 8 was chosen as optimum, as higher pH 
values tend to induce hydrolytic degradation of HA.[162] 
 
Figure 10: The nucleophilic acyl substitution mechanism for methacrylation reaction. 
The reactive OH-group on HA is proposed to be the primary alcohol at the 6-position 




Page 53 of 152 
 
In order to create a reproducible protocol for the methacrylation reaction (see Figure 
11), pH was adjusted to 8 with NaOH every 20 minutes during the first 4 h of 
incubation at RT (dashed lines). Following incubation at RT with repeated pH 
adaption, pH 8 was set before 20 h of reaction at +4 ˚C was carried out without further 
pH adjustment. 
 
Figure 11: Timeline for macromer synthesis with manual pH adjustment. 
Methacrylation reaction was performed in deionised water with the pH being manually 
adjusted to 8.0 using NaOH solution. Adaption of pH (dashed line) was done every 
20 minutes for 4 h at RT, following 20 h at +4 ˚C without further pH adjustment. pH 
levels tended to decrease towards a neutral level over time (full line). 
 
To optimise the handling of pH adjustment, buffer solutions were tested. 
Using 1 M MOPS buffer (3-(N-morpholino)propanesulfonic acid; pKa = 8.07), MOPS 
(23.12 g) was dissolved in deionised water (90 mL). The pH was titrated to pH 8 by 
addition of HCl and topped up with dH2O to a total of 100 mL. 
Using 0.6 M tris buffer (tris(hydroxymethyl)aminomethane; pKa = 8.06), Tris base 
(7.27 g) was dissolved in deionised water (90 mL). The pH was titrated to pH 8 by 
addition of HCl and topped up with dH2O to a total of 100 mL. For 0.3 M tris buffer, 
0.6 M tris buffer was diluted 1:1 with dH2O. 
The following HA-HA-Dopa reaction is catalysed via EDC/NHS coupling reaction (see 
Figure 12). EDC is known to facilitate coupling reaction of carboxyl groups with 
primary amines, by forming a reactive O-acylisourea intermediate of a carboxyl group. 
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This intermediate stage tends to be unstable and benefits from further reaction with 
NHS, which forms a more stable NHS ester group. Consequently, this amine-reactive 
form can react with a primary amine (of the dopamine), allowing sufficient coupling. 
 
Figure 12: EDC/NHS coupling reaction for dopamination. 
EDC reacting with carboxylic acid of HA to form an unstable intermediate that was 
further stabilised with NHS. This complex can react further with the primary amine of 
dopamine to conjugate HA and dopamine together. 
 
Although EDC/NHS reaction could be performed under neutral pH conditions, the 
catechol groups of the dopamine tend to oxidise upon exposure to free protons (i.e. 
pH level or light). Carrying out the reaction under pH 5 and protected from light, 
preserves the reduced state of these reactive groups.[163]  
Corresponding to the degree of modification, macromers were classified as 
no/low/high Dopa and low/high MA (see Table 7 page 71). All macromers have been 
modified with MA groups resulting in low or high DOM. For Dopa, there is also low or 
high DOM, with some macromers not being dopaminated at all. These allowed to 
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investigate any influence and characteristics caused by the Dopa. However, as        
MA-HA hydrogels do not provide sites to stably interact with cells or tissues, MA-HA-
Dopa hydrogels exclusively were considered for biological experiments. 
 
2.2.2 Fabrication of acellular hydrogels 
MA-HA-Dopa and MA-HA macromers aliquoted in amber glass vials got sterilised 
with 54 kGy gamma irradiation and stored at -20 ˚C until further use. Hydrogels were 
formed via step-growth polymerisation by blue light (400 - 500 nm, 500 mW·cm-2), 
facilitated by dithiol-PEG or DTT (65 mM) and Eosin-Y (154 µM; 0.01 wt%) in phenol-
free cell culture media (660 µL). Dithiol/ Eosin solution was sterilised using 0.22 µm 
syringe filters. Macromers (1 or 3 %) were dissolved in dithiol/Eosin solution on an 
Eppendorf Thermomixer (1,400 rpm) at 37 ˚C. In some samples, unmodified 1 MDa 
HA (2 %) was added, to increase the viscosity. Hydrogels were then cast into 
cylindrical glass moulds that had been pre-coated with Sigmacote® (following the 
manufacturer’s protocol) and exposed to blue light (4 minutes).  
 
2.2.3 Viscosity 
To determine the viscosity of the macromer solutions, measurements were carried 
out in triplicates on a HAAKE™ CaBER™ 1 Capillary Breakup Extensional 
Rheometer. Sample volumes of 100 µL were loaded and data acquisition was 
performed at RT. Measurements were done from 0 to 20 Pa·s. Values are reported 
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2.2.4 Gelation kinetics and bulk stiffness 
The time until gelation upon application of blue light (gelation kinetics) and bulk 
stiffness reached after certain time of exposure was measured on a strain-controlled 
ARES rheometer (TA Instruments).  
150 μL viscous macromer solution was loaded onto an 8 mm parallel plate geometry 
(see Figure 13). Dynamic time-sweep experiments were performed at a fixed 
frequency (6.28 rad·s-1) and strain amplitude (0.5 %) and a temperature of 25 ˚C 
controlled by a Peltier unit. The solution was placed on the rheometer plate, and after 
60 seconds, the sample got exposed to light using the OmniCure system with a 5 mm 
fibre-optical light guide and an intensity of 500 mW·cm-2. Measurements were carried 
out for a total of 10 minutes. Gelation time was determined by the cross-over between 
the storage modulus (G’) and the loss modulus (G’’). G’ was determined from time-
sweep curves. Bulk stiffness got analysed for 4 minutes light exposure (set as 
clinically relevant time) and 9 minutes light exposure (maximum bulk stiffness). 
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2.2.5 Shelf-life 
Shelf-life of viscous precursor solution was determined via dynamic time-sweep 
rheology. The bulk stiffness has been set as indicator to reflect shelf-life, comparing 
the change of stiffness over time. Solutions of 3 % MA-HA and MA-HA-Dopa (low/high 
MA, no/low/high Dopa, see Table 7 page 71) without 1 MDa HA, were prepared and 
stored either at either RT or in the fridge (4 ˚C). Samples have been taken after 1 day 
and 8 days, respectively, and measurements were performed as previously described 
(see 0 page 56), with a total of 9 minutes blue light exposure. Values recorded got 
normalised to values of freshly prepared solutions at day 0 (Table 12 page 140) and 
reported as % of initial stiffness G’. Data (n = 3) was analysed via two-tailed Mann-
Whitney test. 
 
2.2.6 Mass swelling ratio 
Hydrogel mass swelling was evaluated via gravimetry. 50 μL cylindrical hydrogels 
were formed in pre-weighed 10 mm petri dishes, submerged in PBS containing 1X 
anti-biotic/anti-mycotic solution (ABAM), and incubated at 37 ˚C for 72 h. PBS was 
removed at 2, 6, 24, 48 and 72 h, wells blotted dry and the sample weighed. 
Experiment has been performed under sterile conditions. Swelling (QW) was 
quantified using the following equation where Wt is the weight of the swollen hydrogel 
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2.2.7 Enzymatic degradation 
To assess enzymatic degradability, swollen hydrogels were placed in 48-well 
suspension plates in a hyaluronidase (HAse) solution (10 U·mL-1) in PBS with ABAM 
(1 %) and incubated at 37 ˚C under standard conditions. HAse was replaced with 
freshly prepared solution every 24 h. Samples have been stored at -20 ˚C.            
Degradation products of HA were quantified by carbazole assay.[164]  Briefly, 50 μL 
of the degradation solution got added to a solution of sodium tetraborate decahydrate      
(25 mM) in concentrated sulfuric acid (200 μL) and heated to 99 °C for 15 minutes. 
Carbazole (0.125 %) in absolute ethanol (50 μL) was then added and solutions briefly 
vortexed. After heating to 99 ˚C for 15 minutes, absorbance of the solution was 
measured on a colorimetric plate reader at 530 nm. The amount of D-glucuronic acid 
has been determined using solutions of known concentrations of the D-glucuronic 
acid sodium salt monohydrate in PBS.  
 
2.2.8 In aqua application 
To demonstrate the hydrogels ability be applied and solidify under aqueous 
conditions, viscous solution (3 %, high MA, low Dopa, no 1 MDa HA) was pipetted 
into a cylindrical mould while fully submerged in water. The material settled to the 
base of the mould and was gelled with blue light. The hydrogel was removed from the 
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2.2.9 Dopa oxidation 
MA-HA-Dopa and MA-HA macromers were dissolved in cell culture media (phenol 
red-free) and incubated at 37 ˚C under standard or hypoxic (5 % O2) conditions for 
72 h. Aliquots were taken at 4, 24, 48 and 72 h. Oxidation was assessed by measuring 
absorbance at 250 - 550 nm. All samples were blanked against PBS or cell culture 
media (no phenol red).   
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2.3 Cell and tissue interaction 
2.3.1 Cytotoxicity 
To determine cytotoxicity of components freely available in the viscous precursor 
solution (before solidification), Eosin-Y as well as PEG and DTT were tested with a 
direct cytotoxicity assay. Therefore, 17IA4 dental pulp cells were grown in Alpha-MEM 
media, supplemented with ABAM (1 %) and FBS (10 %).[165] Cells were cultured to 
80 % confluency and then seeded in 96-well plates at a density of 22,000 cells·cm-2. 
Eosin-Y was tested from 0 - 0.3 wt%, PEG and DTT from 0 - 10 mM. Reagents were 
dissolved in cell culture media and applied to cells. 3-(4,5-dimethylthiazol-2-yl)-2,5-
diphenyltetrazolium bromide (MTT) assay was performed 20 h later, according to the 
manufacturer’s instructions. 
To evaluate cell compatibility with solid hydrogels (after solidification), indirect 
cytotoxicity tests were carried out according to ISO10993-12:2009.[166]         
Hydrogels were prepared using either DTT or dithiol PEG, immersed in cell culture 
medium with a surface to volume ratio of 0.5 cm²·mL-1, and incubated for 72 h under 
standard cell culture conditions to create conditioned media. 17IA4 dental pulp cells 
were seeded in 96-well plates at a density of 22,000 cells·cm-². Conditioned media 
was applied to the cells, and an MTT assay has been performed after 20 h, according 
to the manufacturer’s instructions. 
 
2.3.2 hMSC expansion and maintenance 
Human tissues were obtained from the Imperial College Healthcare Tissue Bank 
(HTA license 12275), which is supported by the National Institute for Health research 
Biomedical Research Centre at Imperial College London (12/WA/0196).           
Samples have been issued from sub-collection R16052. hMSC were isolated from 
bone marrow aspirates collected from the iliac crest of healthy paediatric donors with 
informed consent of their parents.[142] Cells were cultured in αMEM cell culture 
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media with FBS (10 %) and rhFGF (5 ng·mL-1) under standard conditions.                       
At approximately 80 % confluency cells were trypsinised and expanded up to    
passage 7. 
 
2.3.3 Fabrication of cell encapsulated hydrogels 
In order to form hydrogels that contained encapsulated cells, a viscous solution was 
prepared according to 2.2.2, with double the concentration of macromer (2 or 6 %) 
and dithiol/Eosin solution (130 mM/308 µM). Cells were trypsinised, counted and 
diluted accordingly so the viscous solution and cell solution could be mixed 1:1.      
Cells added to the dissolved macromer were homogenised on an Eppendorf 
Thermomixer with 180 g for 15 minutes at 37 ˚C.  
Chondrogenic induction media was composed of DMEM (high glucose, no phenole-
Red, no glutamine, no methionine, no cystine) supplemented with L-glutamine              
(2 mM), Dexamethasome (100 nM), Insulin-Transferrin-Selenium-solution (1 %), 
ABAM (1 %), ascorbic-acid-2-phosphate (50 µg·mL-1), L-proline (40 µg·mL-1) and 
TGF-β3 (10 ng·mL-1). 
In order to increase chondrogenesis of hMSCs, DMOG (200 µM; 35 µg·mL-1) has 
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2.3.4 2D cell attachment 
MA-HA and MA-HA-Dopa hydrogels were formed with additional 5 mg fibronectin per 
mL hydrogel solution, to provide RGD binding sites for cellular integrin interaction. 
150 μL hydrogels were cast in 6-well suspension plates and Sigmacote®-treated 
coverslips placed over them. 17IA4 mouse dental pulp cells (2.5 x 105 cells·cm-2) were 
seeded on top of each hydrogel and incubated for 2 h at 37 ˚C under standard 
conditions (normoxia; 18 – 21 % oxygen) before being topped up with 2 mL media. 
After 16 h, gels were rinsed with pre-warmed media to remove non-attached cells. 
Samples were observed under a light microscope. 
 
2.3.5 3D cell survival 
Live/dead assay was performed to determine whether cells would withstand the 
process of mixing them into the viscous HA solution, application through a narrow 
needle, exposure to the blue light and short-term survival within the solid hydrogel. 
hMSCs (5 x 106 cells·mL-1) were mixed with MA-HA-Dopa or MA-HA solution and 
solidified in cylindrical moulds (see 2.2.2 page 88). Gels were topped up with media 
and incubated for 24 h under standard cell culture conditions before being stained 
with a live/dead kit (Molecular Probes, Invitrogen). Samples got imaged in glass-
bottom slides (MatTek, CCS-8) on a Leica DM16000 confocal laser scanning 
microscope equipped with a physiological chamber set to 37 °C. Red and green 
channels were split in ImageJ. Maxima were counted in the separate channels (as 
described by BRTILifeScience [167]). A minimum of 100 cells have been counted per 
z-stack per sample. Three z-stacks per gel were analysed. 
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2.3.6 Qualitative tissue interaction 
Qualitative evaluation of the interaction of MA-HA (high MA, no Dopa) and MA-HA-
Dopa (high MA, low Dopa) hydrogels (3 %) with fresh tissue was carried out using 
mouse hind limbs (wild type C57BL/6 mouse strain). Hind limbs were skinned, and 
an incision was made in the hamstring muscle with a scalpel. Samples were either 
incubated with sodium periodate solution (8.33 mg·mL-1 in PBS + 0.4 M NaOH in a 
10:1 ratio; active Dopa oxidation, 1 h) or in cell culture media (passive Dopa oxidation, 
72 h). 
For active Dopa oxidation, the hind limb was then dipped in a sodium periodate 
solution. This solution was freshly prepared by mixing sodium periodate                     
(8.33 mg·mL-1 in PBS) with NaOH (0.4 M) in a 10:1 ratio. The viscous hydrogel 
solution was then applied to the cut surfaces and exposed to blue light for 4 minutes. 
After 30 minutes, the cut muscle tissue was pulled apart using forceps and pictures 
as well as videos were captured. Hind limbs were then submerged in PBS + ABAM 
(1 %) and stored under standard cell culture conditions for 5 days before an additional 
movie was captured. 
For passive Dopa oxidation, viscous solution was applied onto the fresh incision and 
exposed to blue light for 4 minutes. Samples were transferred into cell culture media 
and incubated for 72 h at 37 ˚C. Following, samples were pulled apart using forceps 
and pictures were taken. 
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2.3.7 Quantitative tissue adhesion 
Quantitative evaluation of the interaction of MA-HA-Dopa hydrogels with fresh tissue 
was carried out using porcine articular cartilage (adult animals). In order to quantify 
adhesion forces, 3 % MA-HA (high MA, no Dopa) and MA-HA-Dopa (high MA, low 
Dopa) hydrogels were prepared. Porcine articular cartilage was harvested from front 
legs and hind legs of adult animals. Cartilage samples were washed in sterile PBS 
and tissue was removed using a biopsy punch (Ø 8 mm; see Figure 14). HA solutions 
were applied and solidified by 4 minutes blue light exposure. Samples were either 
treated with sodium periodate (8.33 mg·mL-1 in PBS + 0.4 M NaOH in a 10:1 ratio; 
active Dopa oxidation) or incubated in cell culture media for 72 h (passive Dopa 
oxidation). Hydrogel-cartilage samples were mechanically fixed, and weight was 
applied on top of the gel.  
 
Figure 14: Set-up of quantitative adhesion analysis. 
Fresh cartilage samples with MA-HA or MA-HA-Dopa hydrogel were mechanically 
fixed and a push out test was done by applying force on top of the hydrogel. The force 
at which the hydrogel-cartilage-interface failed was recorded.  
 
The weight [m] at which the hydrogel-cartilage-interface ruptured, was recorded via 
gravimetry. Total adhesion force was calculated as followed: 
F [N] = m [kg] × a [m·s−2] 
With [N] = [kg·m·s-2] and acceleration set as 9.81 m·s-2.  
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2.4 Intra- and extracellular matrix formation 
Analysing cell specific protein synthesis and the influence of HIF-1α stabilising factor 
DMOG and different gel formulations was investigated with various techniques.  
 
2.4.1 Non-canonical amino-acid tagging (FUNCAT) 
Cell-encapsulated hydrogels were prepared as described in chapter 2.3.3 (page 61). 
To visualise newly synthesised peptides and proteins, a Click-iT HPG Alexa Fluor 
594 kit was used, following the manufacturer’s instructions. In short, the methionine-
substitute L-homopropargylglycine (HPG) was added to the cell culture media.         
Cells incorporated HPG into the newly synthesised peptide/protein. After incubation, 
hydrogels were rinsed in dH2O and permeabilised with 0.5 % TritonX in PBS for           
15 minutes at RT. Following, Alexa Fluor 594 azide was added for 30 minutes at RT. 
During this reaction time the azide group could bind to the modified alkyne group on 
the HPG via a copper-catalysed click-reaction. Nuclei were stained with an HSC 
NuclearMask blue stain for 30 minutes at RT. Samples were rinsed thoroughly in 
PBS, transferred onto a glass slide and cover slipped. Samples were imaged on a 
DM16000 confocal laser scanning microscope.  
From each group, 4 cell images were selected. Image processing is shown in Figure 
15. First, the cell membrane was identified by Differential Interference Contrast (DIC) 
imaging using a 488 nm laser. ECM was evaluated for distance and detectable protein 
density by generating 20 random lines (blue lines Figure 15) from the membrane to 
the end of the ECM. Protein density, as determined by fluorescence intensity of the 
labelled secreted protein, was measured by analysing the brightness (arbitrary units 
A.U.) of each pixel in radii extending from the cell surface. The fluorescence signals 
were normalised to a line within the cell (positive Alexa signal) and a line in the 
hydrogel (negative background signal), of equal length. Values reported are mean 
(±S.D.). 
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Figure 15: FUNCAT image processing 
Intracellular signals were removed by overlapping fluorescent image with differential 
interference contrast (DIC) images to identify cell membrane; extracellular signal 
intensity and distance was quantified by line plots (n = 80 lines, 4 cells per group with 
20 lines per cell); radial intensity profile represent mean values (with S.D.) as a 
function of distance from the cell membrane. 
 
2.4.2 Raman spectroscopy 
Work with the Raman set-up was performed by collaborating PhD student Anders 
Runge Walther (University of Southern Denmark). Credit for data acquisition, analysis 
and interpretation goes to him. His contribution is summarised in the following chapter 
and was generated together, following his instructions. 
Cell-encapsulated hydrogels were prepared as described in chapter 2.3.3 (page 61). 
Hydrogel samples were thoroughly rinsed with dH2O and transferred onto a MgF2 
glass slide and fully submerged in dH2O. Samples were stored in the fridge over night 
before measurements were taken. Raman imaging was performed on an in-house 
built Raman confocal micro-spectroscope. A 532 nm laser light source (Torus 532) 
was coupled into the microscope (CSE2100) via a 125 µm cladding single mode fiber 
and a fiber collimator. The collimated laser beam was filtered through a laser line filter 
and directed onto a dichroic mirror before being guided a 60x/1.0NA water immersion 
objective (CFI Apo NIR 60X W). The Raman emission collected by the objective was 
guided back through the dichroic mirror and filtered through a long pass filter to 
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remove scattered light before entering the fibre coupler and 50 µm core, low OH 
optical fibre acting as a pinhole to provide confocality. Following, the Raman signal 
was directed to the holographic spectrometer (HS-HSG-532-LF) and detected on a 
thermoelectrically cooled back-illuminated charge coupled device (CCD) spanning a 
spectral range from 0 - 2,500 cm-1. For scanning purposes, a piezoelectric stage was 
used, with a step size of 500 nm and a total acquisition time of 0.3 – 0.8 seconds. For 
3D imaging, a piezo objective mount has been utilised and 2D images were collected 
at parallel planes every 5 µm spanning the entire cell. 
Analysing the raw data was done via spectral processing, using in-house written 
algorithms in MatLab programming environment. Pre-processing of Raman spectra 
involved baseline correction using asymmetric least squares smoothing, cosmic ray 
removal and spectral smoothing by a second order Savitzy-Golay filter with a 9-point 
window in the spectral range 750 - 1,760 cm-1. All individual spectra were normalized 
using the Euclidean vector norm to remove instrument effects. The spectra from all 
Raman 2D and 3D hyperspectral images were unfolded into a single matrix 
comprising more than 160,000 spectra. The N-FINDR algorithm [14] was used to 
unmix the Raman spectra in the dataset and identify pseudo pure biochemical 
components (endmembers). Amount of components (4) has been chosen, that 
maximised the number of biochemically meaningful spectra through peak assignment 
and correlation with literature.[15, 16] The pixels in the hyperspectral images were 
assigned 4 abundance values from 0 to 1 according to their spectral similarities with 
the endmembers using a nonnegative alternating least squares algorithm. Each of 
the 4 abundance value matrices for each image were min-max normalised and 
refolded back into the original shape. The images were plotted by assigning a false 
colour to each endmember channel.  
Relative area quantification for each spectral endmember in an image was performed 
by counting the number of pixels with an abundance value larger than a chosen 
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threshold and calculating the percentage to total area (in pixels) of the cells.                     
A threshold larger than the average abundance value of all images was chosen for 
our application.[17] 
 
2.5 Statistical analysis 
Unless stated otherwise, all values reported are means and error bars represent 
standard deviations (S.D.). Analysis was performed using GraphPad Prism statistical 
software (GraphPad Software Inc., California, USA). Comparisons of the variables 
were performed with the one-way ad hoc ANOVA. When evaluating only 2 groups, a 
t-test was applied. Statistical significance was considered when p ≤ 0.05. 
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3 Results & Discussion 
3.1 Development and characterisation of MA-HA-Dopa hydrogels 
3.1.1 MA-HA and MA-HA-Dopa macromer synthesis 
HA was modified with various degrees of MA. Qualitative and quantitative analysis of 
the resulting MA-HA and MA-HA-Dopa macromers was evaluated via Proton-NMR 
(find plots in Appendix 5.4 page 127 following).   
Table 4 summarises the achieved DOMs. Manual adaption of pH with NaOH resulted 
in a series of methacrylations, ranging from 21 to 65 % of available hydroxyl groups 
modified (see MA21-Dopa0 to MA65-Dopa0). This corresponds to molar feeding 
ratios of HA hydroxyl to methacrylic anhydride from 1:1 to 1:6. Molar feeding ratio and 
achieved level of methacrylation did not follow a linear pattern.  
Table 4: DOMs (pH manually adjusted) 
 
Molar feeding ratio 
   







Total Degree of 
modification [%] 
MA21-Dopa0 1:1 - 21 - 11 
MA30-Dopa0 1:2 - 30 - 15 
MA40-Dopa0 1:2.6 - 40 - 20 
MA47-Dopa0 1:3 - 47 - 24 
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Buffer solutions were tested to maintain the pH at an alkaline level. Starting with a 
feeding ratio of 1:3 (HA:MA), tris buffer resulted in 1 % degree of methacrylation (see 
Table 5). Comparable levels with manual pH adaption (see Table 4) would be at         
47 %. 
Table 5: DOMs (Tris buffer) 
 
Molar feeding ratio 
   







Total Degree of 
modification [%] 
MA1-Dopa0 1:3 0.3 1 < 1 
MA1-Dopa0 1:3 0.6 1 < 1 
 
MOPS buffer resulted in various degrees of methacrylation (see Table 6), with molar 
feeding ratios from 1:3 (= 18 % methacrylation) up to 1:13 (= 33 % methacrylation). 
This is less than half the DOM achieved with manual pH adaption (see Table 4 page 
69) using the same molar feeding ratio of HA:MA.   
Table 6: DOMs (MOPS buffer) 
 
Molar feeding ratio 
   







Total Degree of 
modification [%] 




MA24-Dopa0 1:6 24 12 
MA33-Dopa0 1:13 33 17 
 
The manual adaption of pH for methacrylation was favoured for further experiments.  
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Following methacrylation, dopamination reactions were carried out with molar feeding 
ratios of 1:2.6 of HA:MA, leading to 36 % degree of methacrylation (MA36-Dopa23 
and MA36-Dopa46), which again, is comparable to previous synthesis (MA40-
Dopa0). Levels of dopamination reached from 23 - 46 %. 
As methacrylation and dopamination proven to be a stable and repetitive synthesis, 
a range of different DOMs were created to conduct all further in vitro experiments 
(see MA18-Dopa0 to MA38-Dopa31, Table 7). For low methacrylation MA18-Dopa0 
and high methacrylation MA38-Dopa0 were synthesised. Splitting therefrom, each 
batch was further modified with a low level of dopamination (MA18-Dopa18 and 
MA38-Dopa20), with 18 and 20 % DOM or a high level of dopamination (MA18-
Dopa29 and MA38-Dopa31), with 29 and 31 % DOM. 
Table 7: DOMs double-modification 
 
 
Molar feeding ratio 
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3.1.2 Viscosity 
Hydrogels produced were composed of either 1 % or 3 % modified HA (wt%), as 
summarised in Figure 16. Those reached extensional viscosities of 2.9 ±0.2 Pa∙s         
(1 % solution) and 2.9 ±1.2 Pa∙s (3 % solution). To increase viscosity, unmodified HA 
(1 MDa, 2 %) was added. These solutions were measured as 19.8 ±1.2 Pa∙s (1 % 
solution + 2 % 1 MDa HA) and 34.0 ±9.5 Pa∙s (3 % solution + 2 % 1 MDa HA) 
extensional viscosity.  One-way Anova analysis showed that both solutions 1 % and 
3 % exerted statistical significantly (p = 0.0114 and p = 0.0002) increased viscosity 
due to the addition of unmodified HA (1 MDa, 2 wt%). 1 % and 3 % precursor solutions 
without 2 % 1 MDa HA did not show any statistically significant different viscosity (p 
> 0.9999), whereby addition of 2 % unmodified 1 MDa HA resulted in higher viscosity 
for the 3 % solution (p = 0.0281). 
 
Figure 16: Extensional viscosity of pre-solidified macromer solutions 
Extensional viscosity of 1 and 3 % (wt%) precursor solutions with and without the 
addition of 2 % (wt%) unmodified 1 MDa HA. 1 % and 3 % precursor solutions did not 
show any statistically significant different viscosity (p > 0.9999 (n.s.)), whereby 
addition of 2 % unmodified 1 MDa HA resulted in higher viscosity for the 3 % solution 
(p = 0.0281 (*)). 1 % without/with 2 % unmodified HA (p = 0.0114 (*)) and 3 % 
without/with 2 % unmodified HA (p = 0.0002 (***)). One-way Anova; Plot shows 
means and S.D., n = 3.  
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3.1.3 Gelation kinetics and bulk stiffness 
As indicated in Figure 17, MA-HA and MA-HA-Dopa formulations with low degrees of 
dopamination gelled in less than 4 minutes (taken as the cross-over between G’ and 
G’’). Apart from 1 % formulation without unmodified HA. Non-dopaminated 
formulations gelled within 3 - 16 seconds, low dopaminated took 10 - 145 seconds 
and high dopaminated compositions required 153 - 175 seconds to gel (see Table 10 
page 138, for exact values). Several formulations did not solidify within 4 minutes. 
MA-HA-Dopa with high degrees of Dopa gelled more slowly (> 4 minutes) or not at 
all. For all MA-HA and MA-HA-Dopa (low) formulations, adding 2 % 1 MDa HA did 
not have an adverse effect on gelation time. 
 
Figure 17: Gelation time of different hydrogel formulations 
Gelation times for different hydrogel compositions. Gelation times were grouped so 
that light colour indicates fast gelation and darker colours show slower gelation.            
X indicates compounds that did not solidify. 
 
Bulk stiffness G’ reached after 4 minutes of light exposure is summarised in Figure 
18. Similarly to the observation made with the gelation time (Figure 17), hydrogels 
with no Dopa were stiffer than those with double-modification. Subsequently, 3 % 
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hydrogels appeared stiffer than 1 % hydrogels. The addition of 2 % 1 MDa HA has 
further increased the overall stiffness of the hydrogel, in comparison to the samples 
without. Bulk stiffness for non-dopaminated formulations were 343 - 11,107 Pa,          
low dopaminated reached 173 - 600 Pa and high dopaminated compositions achieved 
37 - 337 Pa (for exact values see Table 11 page 139). 
 
Figure 18: Bulk stiffness of different hydrogel formulations after 4 minutes light 
exposure 
Bulk stiffness for different hydrogel compositions. Values were grouped so that light 
colour indicates softer gels and darker colours show harder gels. X indicates 
compounds that did not solidify. 
 
In order to investigate whether there was full cross-linking achieved, samples were 
exposed to blue light for a total of 9 minutes. Values recorded (Table 12 page 129) 
indicate higher stiffness values for all hydrogel formulations, than after 4 minutes of 
light exposure (Table 11 page 128). Although total kinetic chain formation was 
achieved later, 4 minutes were considered as sufficient time to solidify the hydrogels 
tested. Consistent with observations of gelling time, more extensive Dopa 
modification tended to result in lower values of bulk stiffness G’. 
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3.1.4 Shelf-life 
Shelf-life as a matter of stiffness was investigated via rheology. Storage conditions 
were set to either RT or 4 ˚C, mimicking temperatures required in case drugs or other 
medications are mixed with the precursor solution. In order to measure maximum 
stiffness, hydrogels were exposed to a total of 9 minutes of blue light, as previously 
described (see 0 page 56). G’ after storage was normalised to G’ of freshly prepared 
material (no storage) (see Figure 19 page 76).  
Low MA, no Dopa formulations showed reduced bulk stiffness after 1 day of storage, 
reaching 44 % (RT) and 74 % (4 ˚C). Storing the solutions for 8 days resulted in           
30 % (RT) and 70 % (4 ˚C). Low MA, low Dopa achieved 30 % (RT and 4 ˚C) after     
1 day of storage and did not solidify when stored for 8 days. High MA, no Dopa 
compositions reached 61 % (RT) and 70 % (4 ˚C) after 1 day of storage, and 50 % 
(RT) and 75 % (4 ˚C) after 8 days. High MA, low Dopa hydrogels were at 98 % (RT) 
and 93 % (4 ˚C) after 1 day and resulted in 47 % (RT) and 92 % (4 ˚C) after 8 days 
of storage.  
Overall, solutions stored in the fridge showed higher stiffness’ than those stored at 
RT. Furthermore, most conditions were significantly different from their respective 
control (p<0.05). High MA, low Dopa best preserved G’ over 8 days of storage, 
particularly when kept at 4 ˚C. This formulation showed no statistically significant 
difference compared to its controls (no storage) (#, Mann-Whitney, two-tailed, p = 
0.1), indicating that a precursor solution of this composition can be stored for at least 
8 days prior to use. 
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Figure 19: Shelf-life, G’ normalised to G’ of freshly prepared material (no storage) 
n = 3, mean values with S.D., # = no statistically significant difference (Mann-Whitney, 
two-tailed, p = 0.1). X indicates compounds that did not solidify. 
 
3.1.5 Mass swelling ratio 
Mass swelling ratios were determined via gravimetry, where increases in weight over 
time was recorded as swelling. Time dependent weight changes (Figure 61 page 149) 
were summarised according their plateau swelling behaviour (Figure 20 page 77).  
Significant changes in weight occurred within 2 h after hydrogel formation (One-way 
Anova, p<0.001). Swelling reached a plateau level for all hydrogel formulations 
between 2 - 6 h, except of high MA, high Dopa, which took 24 h to reach maximum 
swelling. Comparing the plateau swelling ratios in Figure 20, low methacrylated 
hydrogels swell about 102 - 255 %, whereby high methacrylated hydrogels tend to 
swell less than 36 - 241 %.   
Increase in dopamination also increased the swelling ratios, especially with the 
addition of 2 % 1 MDa HA. High dopaminated hydrogels showed swelling ratios 
greater than 300 %, which were excluded from further studies. Low dopamination 
increased the swelling ratio for 3 % hydrogel formulations by 35/41 % (+0/2 % 1 MDa 
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HA) for low MA hydrogels, and 210/111 % (+0/2 % 1 MDa HA) for high MA hydrogels, 
compared to the non-dopaminated formulations. Although they solidified during 
rheological bulk stiffness experiments, formulations with 3 % low MA, high Dopa       
(+2 % 1 MDa HA) and 1 % high MA, high Dopa (+2 % 1 MDa HA) disintegrated during 
the swelling experiments and therefore were excluded from the results. 
Overall swelling ratios were between 100 - 250 % for low MA hydrogels, and                
50 - 250 % high MA hydrogels. The swelling behaviour observed is in parallel with 
the materials behaviour for gelation time and stiffness (see 3.1.3).  
 
Figure 20: Summary of mass swelling ratios 
Mass swelling ratios for different hydrogel compositions. Values were grouped so that 
light colour indicates less swelling and darker colours show more swelling. X indicates 
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3.1.6 Enzymatic degradation 
Enzymatic degradation of HA occurs by cellular synthesis and release of 
hyaluronidase (HAse).[168-170] Investigating hydrogel degradability in the presence 
of HAse Type I, confirmed that all compositions are degradable (see Figure 21 and 
Figure 62 page 151).  
Non-dopaminated 3 % hydrogel formulations fully degraded after 48/72 h (+0/2 %       
1 MDa HA) for low MA hydrogels, and 168/216 h (+0/2 % 1 MDa HA) for high MA 
hydrogels. 1 % hydrogels of low MA (+2 % 1 MDa HA) degraded within 24 h (+0 % 
as well 2 % 1 MDa HA) whereas high MA hydrogels took 48 h (+0/2 % 1 MDa HA). 
Degradation times were shorter for dopaminated hydrogels. Low Dopa formulations 
of 1 and 3 % hydrogels degraded within 24 h, except high MA (both 1 % formulations 
and 3 % without 1 MDa HA). All high Dopa hydrogels degraded within 24h. 
Degradation tended to be slower in formulations with higher levels of methacrylation, 
lower levels of dopamination and in the presence of unmodified 1 MDa HA. 
 
Figure 21: Summary of enzymatic degradation  
Time for full enzymatic degradation of different hydrogel formulations. Lighter colours 
indicate fast degradation and darker colours show slower degradation. X indicates 
the absence of gel solidification. 
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3.1.7 In aqua application 
The non-thickened hydrogel solution (3 % high MA, low Dopa; no 1 MDa HA) settled 
down into a ring submerged under water and remained in place for the time of the 
experiment (Figure 22, see also Movie 1). Upon 4 minutes blue light application, the 
material successfully solidified into a hydrogel. As described in 1.3.2 (page 31), a 
change from red to colourless was noticeable after light exposure, indicating Eosin-
mediated cross-linking. 
 
Figure 22: In aqua application. 
Images showing in aqua application of non-thickened viscous solution and gelation 
upon blue light exposure; Scale bar = 10 mm.  
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3.1.8 Dopa oxidation 
After 24 h in cell culture medium, MA-HA-Dopa hydrogels (3 %, high MA, low Dopa, 
no 1 MDa HA) changed from colourless to brown, indicating Dopa oxidation (see 
Figure 23).[56]  
 
Figure 23: Oxidation of MA-HA-Dopa hydrogel 
Images of hydrogels captured directly after gelation (left) or after 24 h incubation in 
cell culture media (right) showing that the hydrogel converts brown, indicating 
oxidation of the Dopa; Scale bar = 10 mm. 
 
Comparing PBS and cell culture media for incubation, hydrogels showed that only 
MA-HA-Dopa formulations incubated in media turned brownish after 24 h incubation 
(Figure 24). Non-dopaminated hydrogels as well as MA-HA-Dopa hydrogels 
incubated in PBS were lacking this effect. 
  
Figure 24: Oxidation of hydrogels in PBS or cell culture media 
Images of hydrogels incubated in PBS (left) or cell culture media (right) for 24 h; MA-
HA-Dopa hydrogels in media are the only group showing the indicative brown colour. 
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This characteristic change was confirmed by colorimetric measurements (Figure 25, 
left), for MA-HA-Dopa hydrogels in cell culture media. Here, absorption between     
250 - 500 nm continued to increase over 72 h (data point not shown). Oxidation under 
hypoxic conditions (5 % O2), as can be found in less vascularised tissues, could be 
slowed by maintaining hydrogels under hypoxic conditions, confirming that 
atmospheric oxygen was sufficient to oxidise the Dopa moiety; however, lower, 
tissue-like levels of O2, could also foster the process. Maximum oxidation for both 
oxygenated conditions could be detected after 120 h. Incubating MA-HA-Dopa 
hydrogels in PBS did not show a comparable increase in Dopa oxidation over the 
same period of time (Figure 25, right).  
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Figure 25: Time course of Dopa oxidation 
Colorimetric measurements of Dopa oxidation in hydrogels maintained in cell culture 
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3.1.9 Discussion 
Developing MA-HA-Dopa hydrogels has strongly focused on clinical application and 
translation into human patients. Therefore, chemical and physical properties have 
been tailored accordingly, with the input of maxillofacial surgeons, dentists and ENT 
specialists. 
Chemical synthesis is primarily done with organic solvents, which are later removed 
via extensive purification processes. However, this requires additional procedures 
which are bearing the risk of contamination or solvents remaining in the final product. 
Chlorinated solvents are amongst the most common to synthesise and modify 
macromers for TE purposes. Such solvents, particularly dichloromethane, which has 
been used by Guvendiren et al.[171] and Lee et al.[56] to create Dopa-modified 
hydrogels, has been associated with neural toxicity. Indeed, exposure to 
dichloromethane has been linked to facial nerve palsy, which is an important concern 
in temporomandibular joint applications, which are in close proximity to the facial 
nerve. The hydrogel system described in this work is based on an aqueous system 
which completely avoids such organic solvents, precluding the need for purification 
or potential toxicity. In order to optimise handling and reproducibility of the MA-HA 
and MA-HA-Dopa macromers, several buffers were tested. Resulting DOMs revealed 
that tris buffer was not sufficient to sustain a stable methacrylation reaction (see Table 
5 page 70), whereby MOPS buffer resulted in increasing DOMs (see Table 6 page 
70), depending on the molar feeding ratio of methacrylic anhydride. The quantity of 
methacrylic anhydride to achieve comparable DOMs as with manual pH calibration 
was several factors higher. Although using MOPS buffer allowed an easy reaction, 
the high amount of methacrylic anhydride necessary was deemed a downside.           
Besides requiring a higher amount of reagent, removal of unreacted compounds has 
to be done much more thoroughly, which is time consuming and costly.   
Consequently, manual pH adaption was chosen for methacrylation reaction as 
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proposed in Figure 11 page 53. Therefrom HA macromers were produced with low 
and high levels of methacrylation. Portions of those were further dopaminated with 
low and high levels of Dopa moieties, creating a total of 6 differently modified HA 
macromers (low MA, no Dopa; low MA, low Dopa; low MA, high Dopa; high MA, no 
Dopa; high MA, low Dopa; high MA, high Dopa), which are summarised in Table 7 
page 71. Those were submitted to further experiments and analysis. 
When preparing the hydrogel pre-curser solution, lyophilised HA macromers (MA-HA, 
MA-HA-Dopa) were dissolved in an Eosin/PEG solution by shaking. Increasing the 
content of HA made those solutions more viscous, whereby, adding more than 2 % 
(wt%) unmodified HA (1 MDa) appeared to be not fully dissolvable. This might be 
overcome by using stirring tools. However, this bears the risk of contamination and 
increases the shear forces within the solution. In case cells are going to be 
encapsulated, high shear forces might damage or destroy those cells.             
Therefore, 2 % unmodified 1 MDa HA was set as maximum to increase viscosity.    
The viscosities reached with the addition of 2 % unmodified HA is comparable to 
commercially available clinical products (see Figure 16 page 72).[158] A number of 
clinicians from different backgrounds (dentists, ENT specialists, maxillofacial 
surgeons) randomly applied and solidified those solutions ex vivo and rated the 
material as easy to handle, with not much introduction necessary. Of course, this is 
relative and might be assessed differently by other end users. 
Hydrogels produced from those precursor solutions possessed a range gelation 
behaviours, which are summarised in Figure 17 page 73. To determine the maximum 
stiffness achievable, the solutions were exposed to a total of 9 minutes of blue light. 
However, timing plays a crucial role during surgical operations as patients are 
supposed to be under anaesthesia for shortest period possible. Consulting with 
clinicians, maximum time for gelation was set to 4 minutes. 
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Step-growth light-activated cross-linking of dithiol-PEG molecules with the MA 
moieties of HA macromers is a time dependent reaction. The longer blue light 
exposure is activating this reaction, the more PEG molecules manage to reach close 
proximity towards a MA group to react with it.  Accordingly, hydrogels exposed to        
4 minutes of blue light appeared to form fewer kinetic chains, and therefore were 
softer, than hydrogels of the same precursor solution being irradiated for 9 minutes 
(see Table 11 page 139 and Table 12 page 140). The amount of kinetic chains formed 
was not only limited by the time active cross-linking molecules were available, but 
also by the quantity of MA moieties to react with. Subsequently, 3 % hydrogels 
appeared stiffer than 1 % hydrogels (see Table 11 page 139 and Table 12 page 140), 
which is to be expected as there are fewer MA moieties present within the same 
volume. This effect was also detectable when comparing the degree of 
methacrylation. Here, low MA hydrogels were comparably softer than same 
formulations with high MA levels (see Table 11 page 139 and Table 12 page 140). 
Interestingly, increase of dopamination leads to a later gelation and softer hydrogels 
(see Figure 17 page 73). This suggests that the Dopa group does not contribute to 
cross-linking, but instead hinders it.  This seems counterintuitive at first, as Dopa is 
known to react with a variety of functional groups and should result in a shorter 
gelation time and stiffer gels, as there are more contributing moieties 
present.  However, this phenomenon is actually an expected result.  Because the 
Dopa-Dopa and Dopa-thiol covalent interactions that would potentially contribute to 
hydrogel cross-linking require the Dopa to be oxidised.[52]  In studies in which Dopa 
is used to covalently cross-link hydrogels, sodium periodate or similar oxidising 
agents are used to enable this reaction.  However, this hydrogel system cross-links 
within minutes, before the Dopa is oxidised.  Under these conditions, the Dopa groups 
are unlikely to participate in any cross-linking reactions and on the contrary are 
inhibiting them instead. In MA-HA-Dopa hydrogels presented in this work, cross-
linking is mainly expected to occur through thiol-ene radical addition. Therefore, 
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catechol ability of scavenging free radicals directly inhibits thiol-ene type cross-links, 
while the regeneration of free catechol after a radical scavenging cycle assures no 
alternative cross-links are formed in this process.[172] Although Dopa can also react 
with free thiols upon oxidation to its quinone form, Dopa exists predominantly in its 
reduced catechol form when hydrogels are formed, which is known to be non-thiol-
reactive.[52] Consequently, the increased free radical scavenging ability at higher 
degree of dopamination is expected to effectively reduce the overall formation of 
elastically active crosslinks and therefore stiffness G’. A similar effect has been 
observed for tough adhesives based on catechol-functionalised thiol–ene polymer 
networks.[173] 
As previously discussed, time and resources are limited inside an operating theatre, 
which renders shelf-life an important factor for a material to be considered practical 
in clinical application. Shelf-life was determined by the ability of a precursor solution 
to form the same amount of kinetic chains, which results in similar stiffness, after 
being stored compared to when freshly produced. Solutions kept in the fridge showed 
higher stiffness’ than those stored at RT, following the assumption that a lower 
temperature slows down natural macromer degradation and reaction of moieties with 
each other (see Figure 19 page 76). Most conditions were significantly different from 
their respective controls, suggesting that those are suitable when prepared freshly. 
High MA, low Dopa formulation best preserved bulk stiffness over 8 days of storage, 
particularly when kept at 4 ˚C. This formulation showed no statistically significant 
difference compared to its controls (no storage), concluding that it is appropriate to 
store for several days after preparation. 
As the nomenclature reveals, hydrogels have a high affinity towards water 
accumulation. Comparing swelling ratios, low methacrylated hydrogels swell about 
100 - 200 %, whereby high methacrylated hydrogels tend to swell less than 100 %. 
This is to be expected, as the higher degree of MA allows a superior interconnection 
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of single methacrylated HA-macromers into the polymeric network. The same effect 
is perceptible with increase in dopamination, as there are less kinetic chains formed, 
which would mechanically restrict the hydrogels network to expand upon influx of 
water. Although an important factor for characterising hydrogel materials, swelling 
might be of less importance for a clinical application in TMD treatments. Performing 
partial surface reconstruction of the fibrous cartilage in TMJ, the hydrogel would be 
surrounded by neighbouring tissue. This mechanically rigid obstruction would hinder 
the gel from swelling in a fashion recorded with in vitro experiments. 
For treatments to be able to achieve a complete tissue regeneration, implants are 
supposed to be degradable. This can be due to chemical cleavage (i.e. hydrolytic 
degradation), mechanical erosion or enzymatic degradation. All hydrogel 
compositions were entirely enzymatically degradable (see Figure 21 page 78). These 
observations were in line with previous reports of degradability in HA with similar 
degrees of modification.[170] Comparing swelling data with degradation behaviour, it 
appears that softer gels tend to degrade on a faster rate. This might be due to less 
material to be degraded (1 % versus 3 %) or higher swelling rates enabling increased 
influx of enzymes into the hydrogel network. Although they solidified during 
rheological bulk stiffness experiments, formulations with 3 % low MA, high Dopa (+2 
% 1 MDa HA) and 1 % high MA, high Dopa (+2 % 1 MDa HA) disintegrated during 
the swelling experiments. Following the trend seen, those formulations might have 
formed only few kinetic chains, which could be broken by movement of the 
surrounding fluid (mechanical erosion). 
As for clinical application, minimally invasive techniques in the TMJ are utilising water-
based buffers to inflate the joint space. Precursor solutions without increased 
viscosity (no addition of 2 % unmodified 1 MDa HA) settled into a levelled volume. 
Solutions of low viscosity appear to settle easily even in liquid environments and could 
be utilised for applications filling more complex shapes. Whereby higher viscosities 
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might permit application in non-horizontal defects. This could be explored further with 
actual minimal-invasive tools, to confirm the effect detected here. 
After being applied and solidified in vivo, Dopa is supposed to be oxidised in order to 
support cell and tissue interactions.[52, 56] Oxidation can be achieved by adding 
active oxidants like sodium periodate or hydrogen peroxide.[56] Unfortunately, these 
are fairly rapid in action and limit the timeframe for application as well as represent 
potential biological toxicity. The mechanism the approach proposed here is that redox 
reactions are occurring spontaneously under physiological conditions, allowing Dopa 
to form a partially oxidised semi-quinone or fully oxidised quinone state. To mimic 
such in vivo conditions, hydrogels were incubated in cell culture media under 
normoxia or hypoxia, showing that only MA-HA-Dopa hydrogels incubated in media 
turned brownish after 24 h incubation (see Figure 24 page 80). This suggests that, 
although molecular oxygen being present, other components like sugars or proteins 
might be necessary to facilitate the necessary redox potential. Concluding, Dopa is 
capable to auto-oxidise under physiological conditions found in cartilage tissue. 
Although this effect takes a few hours to appear, tissue interaction and cell adhesion 
to the injected hydrogel is unlikely to be necessary immediately after application. 
Overall, the MA-HA-Dopa hydrogel system proposed here could resist the liquid 
surrounding it would be exposed during minimally invasive TMJ surgery. The hydrogel 
can be tailored in viscosity, depending on the nature of the defect and is capable of 
supporting primary cell encapsulation. As for clinical applicability, MA-HA-Dopa 
precursor solutions are stable for several days when stored at 4 ̊ C and solidify in less 
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3.2 Cell and tissue interaction 
3.2.1 Cytotoxicity 
Cytotoxicity is a key factor when designing medical implants. This includes synthesis 
of the single ingredients, as well as toxicity before and after gelation. 
Direct cytotoxicity assays show no reduction in metabolic activity with the working 
concentration of 0.01 wt% Eosin (see Figure 26). Increasing the levels to 0.04 wt% 
lowers the activity to approximately 50 %, which amounts to 4x the working 























































Figure 26: Direct cytotoxicity of Eosin 
Direct cytotoxicity of a range of Eosin concentrations. n = 3, mean values with S.D. 
Working concentration of 0.01 wt% did not show a reduction in metabolic activity, 
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Further, 1,4-dithiothreitol (DTT) and dithiolated PEG have been tested via direct 
cytotoxicity assays. As illustrated in Figure 27, DTT and PEG indicate 
cytocompatibility at the working concentration of 0.01 mM. At a concentration of 0.6 
mM DTT lowers cell activity to ~50 %, whereby PEG is tolerated more than 2.25 mM 
before halving metabolic activity. This equals 60x the working concentration of DTT 
and 225x the working concentration of PEG, suggesting that PEG is better tolerated 


























































Figure 27: Direct cytotoxicity of dithiol cross-linking molecules (PEG and DTT) 
Direct cytotoxicity of a range of DTT and PEG concentrations. n = 3, mean values 
with S.D. Working concentration of 0.01 mM did not show any reduction in metabolic 
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Indirect cytotoxicity testing has been performed to exclude the possibility of toxic 
products formed during the hydrogel solidification process. Comparing metabolic 
activity to media only controls, cells treated with PEG cross-linked hydrogel media 
reached 106 %, those incubated with DTT cross-linked hydrogel media resulted in   
89 % (see Figure 28 page 90). As such, both do not exhibit any statistically significant 
toxicity compared to media only controls, however, cells treated with PEG cross-
linked hydrogel media had a statistically significant higher metabolic activity then 
those treated with DTT cross-linked hydrogel media (n = 5, multiple comparison, 
Kruskal Wallis, p = 0.001(***)). These results are in line with the outcomes of the 
single component analysis in Figure 27. 
 
Figure 28: Indirect cytotoxicity of hydrogels formed with PEG or DTT 
Indirect cytotoxicity assays of hydrogels formed with PEG or DTT. n = 5, mean values 
with S.D. Multiple-comparison analysis (Kruskal Wallis, p = 0.001(***)) shows 
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3.2.2 2D cell attachment 
Confirming previous observations [108, 142], cells do not adhere to MA-HA hydrogels 
(Figure 29, left) (3 %, high MA, no Dopa). However, cells do adhere to MA-HA-Dopa 
hydrogels, 16 h after seeding (Figure 29, right) (3 %, high MA, low Dopa). As HA has 
no sites required for integrin-mediated cell attachment, cells are unable to stably 
attach to it, even in the presence of soluble RGD-presenting proteins (i.e. fibronectin).  
 
Figure 29: 2D cell attachment to hydrogel. 
Bright-field images of 17IA4 cells attached to MA-HA (3 %, high MA, no Dopa) and 
MA-HA-Dopa (3 %, high MA, no Dopa) hydrogels after 16 h of culture. Very few cells 
were observed attached to MA-HA hydrogels, compared to the MA-HA-Dopa 
hydrogels. Scale bar = 200 µm. 
 
3.2.3 3D cell survival 
Encapsulating hMSCs in various hydrogel compositions showed high tolerance of 
cells towards preparation and application process , with an overall cell survival of      
73 - 96 % 24 h post-encapsulation (Figure 30 and Figure 63 page 152). 1 % hydrogel 
formulations reported 80/82 % (high MA, no Dopa/high MA, low Dopa) cell survival. 
3 % hydrogels reached 76/93 % (low MA, no Dopa/low MA, low Dopa) and 73/84 % 
(high MA, no Dopa/high MA, low Dopa). All formulations showed increased cell 
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survival for dopaminated hydrogels versus their non-dopaminated compounds.            
1 % hydrogels and 3 % High MA formulations did not result in statistical significant 
increased survival rate; however, cell survival in 3 % low MA formulations was 
statistically significant between no/low Dopa (Fisher’s exact test, n = 3 (total 300 cells 
per condition), p = 0.0014 (**)). 
 
Figure 30: hMSC survival after 24 h encapsulation within hydrogels 
In 3 % hydrogels, cells show significantly higher viability in MA-HA-Dopa hydrogels 
compared to MA-HA hydrogels. Fisher’s exact test, n = 3, total of 300 cells per 
condition. 
 
3.2.4 Qualitative tissue interaction 
Qualitative tissue interaction experiments were performed in order to visualise the 
adhesive properties of MA-HA-Dopa (high MA, low Dopa) hydrogels, and the lack of 
such in MA-HA (high MA, no Dopa) hydrogels, respectively.  
Active oxidation resulted in MA-HA-Dopa hydrogels undergoing the characteristic 
brown colour change within several minutes, indicating Dopa being present in its 
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oxidised form (see Table 8, top row). As the surrounding muscle tissue was moved, 
MA-HA-Dopa hydrogels followed the change and remained adherent (see movie 2). 
This adhesion effect was still visible after 5 days incubation in PBS (see movie 3). 
Non-dopaminated hydrogels on the other hand, were sliding along the tissue, showing 
no significant interaction with the muscle (see Table 8, bottom row). Those were 
floating in the cell culture media after the incubation. 
Table 8: Images hydrogel-tissue interaction via active Dopa oxidation 
3 % MA-HA-Dopa (high MA, low Dopa) and MA-HA (high MA, no Dopa) hydrogels 
adherent/in contact with muscle tissue after treatment to actively oxidise Dopa. As the 
muscle tissue is being pulled apart, the MA-HA-Dopa hydrogel remains adherent to 
the tissue surfaces (see also Movies 2). The MA-HA hydrogel does not stay adherent 
when the tissue is manipulated. Hydrogel borders are indicated in blue. 




















Page 94 of 152 
 
Passive Dopa oxidation via incubation in cell culture media, followed the pattern 
observed with active oxidation. Dopaminated hydrogels interacted with the muscle, in 
parallel to the movement of the tissue (Table 9). Changes visible during movement 
applied to the bulk hydrogel deforming, with the hydrogel-tissue interface appearing 
stable. However, as non-dopaminated hydrogels did not interact with the muscle, they 
were floating in the cell culture media after incubation. This effect could be seen 
already a few hours after starting the incubation. 
Table 9: Images hydrogel-tissue interaction via passive Dopa oxidation 
3 % MA-HA-Dopa (high MA, low Dopa) hydrogels adherent to muscle tissue after 
passive Dopa oxidation. As the muscle tissue is being pulled apart, the MA-HA-Dopa 
hydrogel remains adherent to the tissue surfaces. The MA-HA hydrogel did not 
interact with the tissue and so after 72 h in cell culture media had lost contact with the 
tissue. Hydrogel borders are indicated in blue. 











Although, active Dopa oxidation is not considered in the design of this system, it 
demonstrated an interaction between MA-HA-Dopa hydrogels and tissue and 
excluded any impacts of swelling. This effect was not detectable with MA-HA 
hydrogels. Passive Dopa oxidation experiments reported the same effect but were 
limited due to the swelling of the hydrogels, especially the MA-HA control group.        
As the hydrogels are rather soft, repeated movement eventually lead to a rupture of 
the gel itself, leaving hydrogel residues on the hydrogel-tissue-interface.  
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3.2.5 Quantitative tissue adhesion 
To determine if the Dopa moiety enabled stable tissue interactions, MA-HA and MA-
HA-Dopa hydrogels were formed within circular defects punched out of mature 
porcine articular cartilage explants. Catechol moieties were either actively oxidised 
(NaIO4) or allowed to undergo passive oxidation (cell culture media) before 
quantifying the force required to push the hydrogel out of the tissue. For active 
oxidation, this resulted in 141 ± 6 µN (MA-HA-Dopa) and 8 ± 1 µN (MA-HA) of force 
needed (see Figure 31), which is 17x higher force required to push out MA-HA-Dopa 
hydrogel. Passive oxidation reached necessary push-out forces of 61 ± 8 µN (MA-
HA-Dopa) and 5 ± 1 µN (MA-HA), which is 12x higher force necessary to push out 
MA-HA-Dopa hydrogel. Both, actively and passively oxidised Dopa-modified 
hydrogels required significantly higher push out forces than their MA-HA counterparts 
(Unpaired t-test with mean values and S.D., n = 3, p = 0.0035(**) and                                   
p < 0.0001(****)), confirming tissue adhesive properties of MA-HA-Dopa hydrogels. 
 
Figure 31: Quantitative tissue adhesion 
Force required to push hydrogel (3 %; high MA, low Dopa; high MA, no Dopa) out of 
circular defect created in porcine articular cartilage, either after being actively oxidised 
with NaIO4 or passively oxidised in cell culture media over 72 h. Unpaired t-test with 
mean values and S.D., n = 3, p = 0.0035(**) and p < 0.0001(****). 
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3.2.6 Discussion 
Besides physical and chemical properties discussed in 3.1.9 (page 82), biological 
characteristics of MA-HA-Dopa hydrogels have been explored. Here, the immediate 
effect of hydrogel formulations upon cells as well as interaction with fresh tissue 
explants has been investigated. 
Cytotoxicity is a major factor throughout this project and has been focused on during 
synthesis of MA-HA and MA-HA-Dopa macromers. MA-HA and HA-Dopa constructs 
have been used by previous groups, which have shown that they do not emit any 
cytotoxic components.[108, 174] Additional soluble components are Eosin-Y, as well 
as the dithiol cross-linking molecules (PEG and DTT). These could potentially be 
available to cells before undergoing a covalent reaction with the HA-macromers, or if 
not consumed during the solidification process. Held et al. have previously explored 
cytotoxic effects of DTT in cell culture experiments, confirming 0.01 mM as non-toxic 
concentration.[175] DTT is known to facilitate additive reactions via Michael-addition, 
which has been utilised to produce self-assembling hydrogel networks.[176, 177] 
These networks form within a few minutes under physiological pH conditions.[177] 
Considering the significantly higher cytotoxicity, it appears that the reactive thiol 
groups of DTT are more active than those linked to the PEG. This was further backed 
up by the fact that solutions with PEG did not spontaneously gel. Testing a wide range 
of concentrations with the single components as well as fully solidified hydrogels has 
proven to be well tolerated by cells, without reduction of cellular viability (see 3.2.1 
page 88). 
Besides the cytocompatibility, gelling behaviour might be a significant factor when 
evaluating a cross-linker. DTT is a short molecule that connects MA groups which are 
near each other. PEG, in contrast, is a longer and more flexible cross-linker which 
could connect MA moieties that are located further away from one another.           
During the cross-linking process HA macromeres will be trapped in position, leaving 
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more flexible PEG molecules to reach out and connect the MA groups.         
Concluding, further experiments have been performed using only PEG as cross-
linking molecule. 
Comparing 2D cell interaction with MA-HA and MA-HA-Dopa hydrogels, it became 
obvious that cells managed to interact with MA-HA-Dopa formulations within a short 
period of time. Following auto-oxidation of the catechol group, dopaminated hydrogel 
compositions should decorate themselves with soluble proteins in an in vitro setting. 
Once a semi-quinone or quinone has covalently attached to a protein, it is no longer 
susceptible to redox reactions and therefore firmly bind to each other. This ultimately 
leaves all catechol groups in MA-HA-Dopa hydrogels attached to a soluble or tissue-
bound protein over time in in vitro or in vivo conditions. Serum proteins could foster 
integrin-based cell interactions with the hydrogel.[52, 178] Consequently, having no 
RGD-containing soluble protein to interact with would not permit a swift integrin-based 
cell interaction with MA-HA-Dopa hydrogels. The same effect was seen for cells 3D 
encapsulated in hydrogel formulations. Cells did survive in MA-HA as well as in MA-
HA-Dopa hydrogels which confirms previous reports that hMSC can thrive within HA-
based hydrogels lacking adhesive motifs.[179-181] In fact, cells have demonstrated 
to rather swiftly create their own proteinaceous matrix which they can actively probe 
via cell receptors like integrins.[63, 182] Additionally, Vining and colleagues have 
proven that this effect is genuine even in the absence of serum proteins.[183] 
Nevertheless, for a clinical setting it can be expected for soluble proteins to be present 
to some extend within the surrounding of the applied hydrogel. This could be due 
proteinaceous components originating from the synovial fluid, the microfracture 
procedure and tissue residuals of abrasive processes. In addition, 3D encapsulation 
experiments are suggesting that the presence of Dopa in hydrogel constructs might 
enhance overall cell survival. Taken together, these observations show that by 
providing sites for protein interaction and thus integrin-mediated interactions, MA-HA-
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Dopa hydrogels can potentially deliver viable cells or be infiltrated by endogenous 
cells made available using procedures such as microfracture.[184-186] 
Integration of neo-cartilage into the surrounding host tissue is an important factor for 
a material to succeed in cartilage regeneration.[49] Lacking a vascular network 
combined with limited self-repair remains challenging for regeneration to occur via 
hMSCs or chondrogenic cell types. However, loading the cartilage might increase 
influx of water and nutrients. This could be further enhanced by the swelling of the 
hydrogel network itself, however, expansion of the applied material might be restricted 
due to the surrounding host tissue (see Figure 4 page 30). This swelling could further 
support firm interaction of the hydrogel with the native cartilage, enhancing adhesive 
connections  via catechol groups. Adhesive strategies utilising components other than 
mussel-inspired catechols have been explored for arthroscopic approaches (see 
1.3.3 page 35). Those have limited to no application in arthroscopic approaches as 
they either have to be applied as a liquid, and would be washed away within the liquid 
environment of the inflated TMJ space, or require the addition of potentially toxic 
components.[130-135] 
When interacting with a tissue-bound protein, Dopa is supposed to facilitate tissue 
adhesion. Qualitative results demonstrated a fairly stable connection for MA-HA-
Dopa hydrogels when actively or passively oxidised (see 3.2.4 page 92, and movies 
2 and 3). Even though the mechanical strain applied here is not what would to be 
expected in a clinical setting, the results indicate a tissue-hydrogel interaction, 
stronger than the actual kinetic chains within the hydrogel. Quantifying strength of 
adhesives is largely validated via lap-shear tests [187, 188] or peel tests [189, 190]. 
Such tests require a thin layer of adhesive agent in comparison to a large interface 
area. Those approaches should minimise the influence of the materials property, and 
only focus on the material-tissue interaction. Qualitative tissue interaction 
experiments concluded, that the MA-HA-Dopa hydrogel is posing a weaker physical 
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resistance then the hydrogel-tissue interface. Approaching the quantification of 
adhesion forces between MA-HA-Dopa hydrogels and tissue has proven challenging. 
The application of light was a limiting factor, as the hydrogel layer was too thin and 
uneven for the light to properly penetrate and therefore cross-link the viscous gel 
solution. Consequently, and in line with the proposed clinical application (see 1.3.1 
page 29), a push-out test was utilised to quantify adhesion of MA-HA and MA-HA-
Dopa hydrogels to mature porcine cartilage. Results clearly indicate a catechol-
dependent adhesion of MA-HA-Dopa hydrogels to cartilage tissue explants when 
exposed to physiological conditions, without the addition of further oxidising agents 
(see Figure 31 page 95).  
Summarising, MA-HA-Dopa hydrogel systems proposed in this project represent a 
highly cyto-compatible material, that is likely to be suitable for maxillofacial 
applications. Cellular and tissue adhesion is supported in wet environment without 
the addition of potentially harmful oxidising agents and would not require secondary 
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3.3 Intra- and extracellular matrix formation 
3.3.1 Non-canonical amino-acid tagging (FUNCAT) 
After 21 days in culture, newly synthesised peptides/proteins were visible 
intracellularly as well as in the pericellular space under all conditions (representative 
images in Figure 32A, B, C and D). To better understand the distribution and density 
of the secreted matrix, radial fluorescence intensity profiles of the HPG signals 
extending from the cell membrane of encapsulated cells have been plotted as mean 
intensity over distance (Figure 32A’, B’, C’ and D’).  
hMSCs encapsulated in 1 % hydrogels indicated HPG positive signals up to           
42/31 µm (without/with DMOG) from the plasma membrane. In 3 % hydrogel 
compositions, HPG positive signals were detected up to 31/37 µm (without/with 
DMOG) from the cell membrane.  
Quantitatively comparing the overall intensities from each group via two-tailed Mann-
Whitney test, showed no statistically significant increase in fluorescence intensity 
when treating hMSCs with DMOG in 1 % hydrogels (p = 0.5101). hMSCs in 3 % 
hydrogels revealed a statistically significant increase in HPG positive signal when 
being treated with DMOG (p = 0.0042). Comparing the different hydrogel 
compositions without DMOG, hMSCs in 1 % hydrogels released significantly more 
HPG positive peptides/proteins into the pericellular space then cells in 3 % hydrogels 
(p = 0.0002). The same response was detectable for DMOG treated groups, where    
1 % hydrogels also exhibited significantly higher intensities over 3 % hydrogels (p = 
0.0222). For 3 % hydrogel compositions, hMSCs treated with DMOG resulted in HPG-
signal intensities, which are comparable levels to those in 1 % hydrogels without 
DMOG (p = 0.9792), but significantly less than in 1 % hydrogels with DMOG (p = 
0.0222). 
Those observations showed that in all conditions, pericellular matrix PCM formation 
was concentrated immediately around the cell membrane. DMOG showed limited 
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impact upon peptide/protein secretion in 1 % hydrogels. However, in 3 % hydrogel 
compositions the presence of DMOG resulted in production of more HPG signal and 
at larger distances from the cell membrane as the control group without DMOG.           
In total, hMSCs encapsulated in 1 % hydrogels treated with DMOG resulted in highest 
HPG-positive signals after 21 days in incubation. 
 
Figure 32: Fluorescent non-canonical amino acid tagging to visualise secreted 
peptide and protein contents. (figure legend continuing on next page) 
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FUNCAT analysis on 1 % and 3 % MA-HA-Dopa hydrogels (no 1 MDa HA) 21 days 
post encapsulation. Each group shows a representative cell image (A, B, C and D) 
with HPG signal in red and nuclei in blue. Error bar = 40 µm. Summarising FUNCAT 
plot of n = 4 cells (A’, B’, C’ and D’) show mean values in orange with S.D. in grey. 
(A) 1 % hydrogel without DMOG; HPG signal was detected as far as 42 µm from the 
cell membrane;  (B) 1 % hydrogel with DMOG; HPG positive signals were detected 
up to 31 µm from the cell membrane; (C) 3 % hydrogel without DMOG; HPG positive 
proteins were detected up to 31 µm from the cell membrane; (D) 3 % hydrogel with 
DMOG at 21 days; HPG positive signals were detected up to 37 µm from the cell 
membrane; no statistical significant difference was detected for the 1 % hydrogel 
groups (A) and (B) (Mann-Whitney test, p = 0.5101); for 3 % hydrogels, DMOG treated 
group (D) compared to group without DMOG (C) confirmations a statistical 
significantly higher amount of HPG positive peptides/proteins in the DMOG group 
(Mann-Whitney test, p-value = 0.0042); hMSCs in 1 % hydrogel compositions (A) and 
(B) secreted more peptides/proteins into their pericellular space, compared to 3 % 
groups (C) and (D). Overall, 1 % hydrogel with DMOG (B) developed the highest 
HPG-positive signal intensities. 
 
3.3.2 Raman spectroscopy 
Work with the Raman set-up was performed together with collaborating PhD student 
Anders Runge Walther (University of Southern Denmark). Following experimental 
design and preparation of hydrogel samples, remaining credit for data acquisition and 
analysis goes to him.  
Raman micro-spectroscopy was utilised to visualise hMSCs after cultured in MA-HA-
Dopa hydrogels (3 %; high MA, low Dopa; no 1 MDa HA) for 21 days with and without 
the addition of HIF-1α stabilising factor DMOG. Multivariate image processing of the 
entire hyperspectral dataset produced 4 pseudo pure spectra (endmembers) 
describing the biochemical composition of the cells and their immediate surrounding 
(see Figure 33B). Cell image reconstruction were conducted by assigning abundance 
values to each pixel in the images according to their spectral similarity with the 
endmembers (see Figure 33A).  
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The endmembers (Figure 33B) show typical protein Raman bands for Amide I   
(~1,654 cm-1), Amide III (~1,255 cm-1), Phenylalanine (1,034 cm-1 and 1,003 cm-1). 
The spectra representing the proteinaceous contents (Figure 33B, cyan and blue) 
show some dissimilarities. The cyan endmember exhibits a broad and intense peak 
in the Amide III region with high intensity in the range 1,250 - 1,300 cm-1 relative to 
the amide I band calculated using the respective band areas. Previously published 
work have shown this to be associated with α-helix secondary structure in proteins 
such as collagen.[191] The blue endmember shows an Amide I shoulder around 
1,610 cm-1 usually assigned to cytosine, tyrosine and tryptophan and has a lower 
intensity in the Amide III region 1,250 - 1,300 cm-1 relative to the Amide I band.         
The nucleus spectrum contains additional bands associated with DNA and RNA 
around 1,340 cm-1 (Nucleic acid mode) and 828 cm-1 (O-P-O stretch).[192] The final 
endmember (yellow) contains spectral features associated with lipids around        
1,130 cm-1, 1,303 cm-1 and 1,674 cm-1.[191] Movie 4 demonstrates a 3D Raman 
image of a primary human mesenchymal stromal cell encapsulated in a MA-HA-Dopa 
hydrogel, showing the spectra discussed.  
Differences due to the influence of DMOG was determined by relative area 
quantification in which the number of pixels associated with the respective 
endmembers are counted and related to the total number of pixels in each cell. 
Results show that the largest difference is found in the cytoplasmic content of the 
cells where hMSCs exposed to DMOG exhibit more of the cyan coloured 
proteinaceous endmember although not statistically significant (Mann-Whitney test, 
p-value = 0.11). This suggests that DMOG has increased the production of proteins 
21 days post encapsulation. 
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Figure 33: Raman imaging and quantitative analysis of encapsulated hMSC 
biochemical composition. 
(A) Representative Raman images of hMSCs cultured without (I-III) and with DMOG 
(IV-VI);  Pairs of images (I-VI) represents the same cell showing nucleus (red) along 
with proteins (cyan, blue) and nucleus with lipid content (yellow); Scale bar = 10 µm.                            
(B) The corresponding Raman spectral endmembers of subcellular components 
extracted using the NFINDR algorithm (showing 4 components); from top to bottom 
lipids (yellow), proteins (cyan, blue) and nucleus (red). (C) Relative area quantification 
and comparison of the subcellular composition for cells cultured with (n = 5) and 
without DMOG (n = 4). Mann-Whitney test resulted in no statistically significant 
difference between the groups.  
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3.3.3 Discussion 
Observations suggested that a combination of FUNCAT and Raman spectral imaging 
could provide unbiased in situ visualisation of both cells within 3D hydrogels and their 
secreted matrix. In detail, FUNCAT data provided quantitative insight about secretion 
and distance of newly synthesised peptides/proteins from the cellular plasma 
membrane, which indirectly gives feedback about hydrogel behaviour.                   
Raman imaging supplements that with qualitative input about the properties of this 
newly formed ECM.  
Overall, quantity and distance of HPG-positive signals is comparable to similar 
systems published by our team as well as other groups.[63, 160] 1 % hydrogel 
formulations enabled hMSCs to produce vast quantities of peptides/proteins and to 
secret them into their pericellular space. Here, DMOG did not seem to have significant 
effects on quantity or distance of HPG-positive signals. In 3 % hydrogel formulations 
on the other hand, DMOG statistically significantly increased both distance and 
intensity of stained peptides/proteins in the extracellular space. This effect might be 
resulting from the higher density of hydrogel being present in 3 % compositions, as 
the hydrogel might sterically restrict secretion to a greater extent than in 1 % 
hydrogels, which is also more easily amendable by cells. Cell-active components like 
DMOG have been deemed potentially valuable for chondrogenic TE 
approaches.[193-196] DMOG has shown to strongly target chondrogenic gene 
expression, suggesting that it might support hMSCs to undergo differentiation. 
Taheem and colleagues[21] have shown that DMOG could be utilised for cartilage 
regeneration by inhibiting FIH and PHD2 hydroxylases, upregulating HIF-mediated 
transcription to support chondrogenesis. They added that DMOG reduced expression 
of hypertrophy associated type X collagen. Furthermore, early DMOG administration 
appeared to strongly induce chondrogenesis, however, it also reduced expression of 
collagen type II when administered initially. Exposure of DMOG 14 days after hMSCs 
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encapsulation resulted in elevated chondrogenic expression profile, with no negative 
impact on cartilage-like ECM formation. This concludes that a delayed release of 
DMOG might increase the secretion of cellular proteins. 
As both HA-based hydrogels and DMOG are known to enhance hMSC 
chondrogenesis, next steps planned are to confirm these unbiased visualisation 
techniques by carrying out immunostaining for collagen type I and II. Fibrocartilage of 
TMJ articular surface is mainly composed of those two collagen types.             
Therefore, examining the proteinaceous content and presence of 
glycosaminoglycans of matrix secreted by those encapsulated hMSCs should allow 
to make more competitive assumptions about what formulation has the highest 
probability of restoring fibro-cartilage in vivo.  
Work with the Raman set-up was performed together with collaborating PhD student 
Anders Runge Walther (University of Southern Denmark). Discussion of Raman 
results is kept general and focused on the benefits it gained for this project: Utilising 
Raman spectral imaging has proven as quick and versatile technique to investigate 
3D encapsulated cells within MA-HA-Dopa hydrogels. Compared to conventional 
techniques, samples did not require time consuming preparation like sectioning or 
further staining. Raman imaging resembles a non-invasive, non-destructive method 
for in vitro purposes. Data collected allows unbiased as well as biased analysis of 
chemical compositions.[197-199] N-FINDER algorithms like the one used in this 
approach can discover various chemically different components within a small spot. 
Searching for a specific chemical component allows biased, targeted investigation of 
materials present. However, specificity that can be achieved with i.e. 
immunohistochemistry cannot be accomplished with Raman and FUNCAT alone and 
would benefit from supporting techniques. Analysing for elements of native cartilage 
components, immunohistochemistry allows to further chemically characterise the 
neo-tissue formed. This will allow to draw conclusions about what type of cartilage-
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like ECM is being produced. In addition, overlapping with the non-canonical amino-
acid tagging data, this can give information about what portion of the newly 
synthesised matrix is located at what distance to the producing cell.  
In summary, hMSCs encapsulated in MA-HA-Dopa hydrogels do synthesise and 
secrete peptide/proteins into their pericellular space. DMOG is capable of significantly 
increasing protein secretion for 3 % hydrogels. Exploring new techniques to evaluate 
the formation of such ECM components, Raman spectral imaging combined with 
FUNCAT analysis bears great potential to serve as a multitalented and high-
throughput system to visualise and evaluate hydrogels for TE purposes.   
Christoph Salzlechner 
Page 108 of 152 
 
4 Conclusion & future directions 
Summarising results and discussion, the aims of this project are considered as 
achieved successfully. Presented here is a double-modified hydrogel system, which 
can be synthesised without any potentially neurotoxic reagents, in a highly controlled 
environment. Chemical, physical and biological properties have been tailored for 
usage in arthroscopic surgery in maxillofacial applications, specifically the articular 
cartilage of the TMJ. As such, a range of different precursor solutions with various 
viscosities can be created, to permit application within a liquid environment and 
solidify rapidly when exposed to standard clinical blue light. These hydrogels also 
promote survival of primary human cells and enable delivery of cyto-active agents 
(i.e. DMOG). As a result, cells not only survive application and solidification of the 
hydrogel material but also produce and secrete matrix components into their 
immediate pericellular space. This was evaluated as first in vitro indication for 
potential tissue regeneration. Besides allowing easy handling and no specialised 
equipment necessary, hydrogel precursor solutions can be applied, moulded and if 
required removed and reapplied, before solidifying, making it an exceedingly 
adaptable material to work with. Precursor solutions can also be prepared upfront and 
stored for several days before use, rendering this system even more suitable for 
clinical translation. This novel material, its synthesis and characterisation has been 
published in Advanced Healthcare Materials (see 5.1(1) page 124). Currently, Raman 
and FUNCAT data is being drafted into a follow-up publication, to be considered soon 
for submission to a suitable journal (see 5.1(2) page 124).  
At the current stage of this project, there have been hydrogel compositions identified 
that could potentially facilitate formation of articular fibro-cartilage. Hence, the next 
stage is aimed to be an in vivo study. This should give further insights into clinical 
applicability of the precursor solution and its potential for neo-tissue formation.               
In order to investigate optimal tissue development conditions, it would be of interest 
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to compare different cell sources like BM-MSCs from microfracturing, as well as 
directly incorporated primary cells like mature chondrocytes. MSCs would allow 
administration via microfracturing techniques, minimising the need of additional 
procedures. Furthermore, those are available in large quantities and do recovery 
naturally.[200] They can be driven towards tissue-specific lineages, which here was 
investigated by the administration of HIF-1α stabilising factor DMOG.                      
Mature chondrocytes on the other hand are considered to have a high potential for 
ECM synthesis and secretion.[201] Repeating 2D adhesion experiments with serum 
versus serum-free cell culture media should demonstrate that cells are lacking 
capability of interaction with either MA-HA or MA-HA-Dopa gels. Specifically blocking 
integrin-interactions could further prove the role of integrins in these adhesion 
processes.[202, 203] When encapsulated, comparing serum with serum-free 
conditions could confirm previous observations, that cells within 3D hydrogels are 
capable of secreting their own proteinaceous matrix, even when serum proteins are 
absent.[63, 182, 183] Analysing these two conditions, FUNCAT combined with 
Raman might give detailed insight into the time course of matrix secretion as well as 
potential differences in their composition. Furthermore, complexity of the hydrogel 
environment is changed drastically in in vivo studies contrasted to in vitro 
surroundings. Besides chemical differences like growth factors and oxygen gradients 
occurring[204], cellular components like immune cells[205] and neighbouring tissue-
specific cells can influence the behaviour of cells present within the hydrogel.            
This will further be affected by mechanical compression forces, which are considered 
to be a major driving factor for osteochondral reconstruction.[206] 
Extending the impact of this project beyond the immediate aims, contributions to other 
projects have led to various co-authorships (see 5.2 page 124). 
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5.3 Supplementary movies 
Movie 1: To demonstrate a sol-gel transition under aqueous conditions, the viscous 
solution (3 %, high MA, low Dopa, no 1 MDa HA) was pipetted into a 
cylindrical mould while fully submerged in water. The material settled to the 
base of the mould and was gelled with blue light. The hydrogel was 
removed from the mould after 4 minutes light exposure. 
Movie 2: To demonstrate how Dopa-modified hydrogels adhere to tissue, a deep 
incision was made in the muscle of a mouse hindlimb. The muscle was 
then coated with sodium periodate to foster Dopa oxidation. The hydrogel 
precursor solution (3 %, High MA, low Dopa) was pipetted into the incision 
and exposed to blue light for 4 minutes and then left at RT for 30 minutes 
before recording the video. As the muscle tissue is pulled apart, the 
hydrogel remains adherent to the tissue surfaces. 
Movie 3: To demonstrate the stability of the MA-HA-Dopa hydrogel-tissue 
interaction, the sample in Movie 2 was incubated for 5 days in PBS at          
37 °C and the test repeated.  
Movie 4: The movie demonstrates a 3D Raman image of a primary human 
mesenchymal stromal cell encapsulated in a MA-HA-Dopa hydrogel.       
The biochemical components of the cell identified using spectral unmixing 
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5.4 1NMR spectra 
Figure 34 summarises the peaks to be expected according to 1H-NMR for the single 
methacrylation as well as dopamination and methacrylation double-synthesis.            
1H-NMR spectra show a methyl peak (CH3) for hyaluronic acid at ~ δ 2.1 ppm (A). 
Signals referring to methacrylation appeared at ~ δ 5.7 ppm and ~ δ 6.5 ppm (C), 
which refer to the methylene group of the coupled methacrylate (C=CH2). Signals 
referring to dopamination refer to the hydrogens in the ring (-CH2), appearing between 
~ δ 6.5 ppm to ~ δ 7.3 ppm (F).  
Peaks not used for quantifying the DOM are protons in N-terminus of Dopa (-CH2) at 
~ δ 2.8 (E), methyl group in the methacrylate (CH3) at ~ δ 1.95 (B) as well as the 
proton of the secondary amine in N-acetylglucosamine at ~ δ 4.5 (D). Further peaks 
are generated by deuterium as solvent at ~ δ 4.8 (D2O) and the hydrogens in the HA 
backbone at ~ δ 3.2-4.2 (HA hydrogens). 
 
Figure 34: NMR peaks corresponding to protons. 
HA can be detected via methyl peak (CH3) for at ~ δ 2.1 ppm (A)  and the secondary 
amine in N-acetylglucosamine at ~ δ 4.5 (D), as well as aromatic groups at ~ δ 3.2-
4.2. MA can be identified by methyl group ~ δ 1.95 (B) and methylene group at ~ δ 
5.7 ppm and ~ δ 6.5 ppm (C). Dopa can be identified by N-terminus of Dopa (CH2) at 
~ δ 2.8 (E) and hydrogens in the ring (CH2), ~ δ 6.5 ppm to ~ δ 7.3 ppm (F).  
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5.4.1 1NMR plots for methacrylation reaction 
Plots referring to manually adjusted pH protocol (Table 4). 
 
Figure 35: NMR plot for macromer MA21-Dopa0. 




Figure 36: NMR plot for macromer MA30-Dopa0. 
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Figure 37: NMR plot for macromer MA40-Dopa0. 





Figure 38: NMR plot for macromer MA47-Dopa0. 
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Figure 39: NMR plot for macromer MA65-Dopa0. 
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5.4.2 1NMR plots for methacrylation (Tris) 
Plots referring to Tis buffered methacrylation reaction (Table 5). 
 
Figure 40: NMR plot for macromer MA1-Dopa0. 





Figure 41: NMR plot for macromer MA1-Dopa0. 
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5.4.3 1NMR plots for methacrylation reaction (MOPS)  
Plots referring to MOPS buffered methacrylation reaction (Table 6). 
 
Figure 42: NMR plot for macromer MA18-Dopa0. 





Figure 43: NMR plot for macromer MA24-Dopa0. 
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Figure 44: NMR plot for macromer MA33-Dopa0. 
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5.4.4 1NMR plots for double-modified HA  




Figure 45: NMR plot for macromer MA36-Dopa23. 
Spectra show presence of HA (A, HA and D) as well as MA groups (B, C), Dopa 




Figure 46: NMR plot for macromer MA36-Dopa46. 
Spectra show presence of HA (A, HA and D) as well as MA groups (B, C), Dopa 
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Figure 47: NMR plot for macromer MA18-Dopa0. 





Figure 48: NMR plot for macromer MA18-Dopa18. 
Spectra show presence of HA (A, HA and D) as well as MA groups (B, C), Dopa 
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Figure 49: NMR plot for macromer MA18-Dopa29. 
Spectra show presence of HA (A, HA and D) as well as MA groups (B, C), Dopa 




Figure 50: NMR plot for macromer MA38-Dopa0. 























Page 137 of 152 
 
 
Figure 51: NMR plot for macromer MA38-Dopa20. 
Spectra show presence of HA (A, HA and D) as well as MA groups (B, C), Dopa 




Figure 52: NMR plot for macromer MA38-Dopa31. 
Spectra show presence of HA (A, HA and D) as well as MA groups (B, C), Dopa 
























Page 138 of 152 
 
5.5 Gelation behaviour and bulk stiffness 
Figure 17 represents the gelation behaviour of different hydrogel formulations after    
4 minutes of light exposure, with Table 10 summarising the exact values.  
Table 10: Summary of gelation times [37] after 4 minutes light exposure 
Summary of gelation times [37], as determined by the cross-over of G’ and G’’. 
Formulations that did not achieve a sol-gel transition after 4 minutes light exposure 
are indicated with an X. 






1 % 3 % 1 % 3 % 1 % 3 % 
Low 
MA 
+ 0 % X 5 X 114 X X 
+ 2 % 11 3 10 143 X X 
High 
MA 
+ 0 % 16 5 145 138 X X 
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Table 11 summarises the bulk stiffness reached after 4 minutes light exposure.        
This time-point has been set as clinically relevant. 
Table 11: Summary of stiffness of hydrogels after 4 minutes light exposure 
Stiffness of hydrogels as determined by the elastic modulus G’ (Pa) after 4 minutes 
light exposure. Data show means and standard deviations. Formulations that did not 
achieve a sol-gel transition after 4 minutes light exposure are indicated with an X. 
Stiffness [Pa ±S.D.] 
4 min light exposure 






1 % 3 % 1 % 3 % 1 % 3 % 
Low 
MA 





























37      
±4 
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Table 12 summarises the plateau stiffness reached after 9 minutes light exposure.    
As can be seen in Figure 53 - Figure 56, bulk stiffness reached its maximum value 
later than 4 minutes light exposure.  
Table 12: Summary of stiffness of hydrogels after 9 minutes light exposure 
Plateau stiffness of hydrogels as determined by the elastic modulus G’ (Pa) after           
9 minutes light exposure. Data show means and standard deviations.          
Formulations that did not achieve a sol-gel transition are indicated with an X. 
Stiffness [Pa ±S.D.]  






1 % 3 % 1 % 3 % 1 % 3 % 
Low 
MA 
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Figure 53: Gelation kinetics and hydrogel stiffness of 1 % hydrogels (without 2 % 
unmodified 1 MDa HA) 
Gelation kinetics and hydrogel stiffness as measured by the storage (G’ ) and loss 
(G’’ ) modulus by small amplitude oscillatory time-sweep rheology of 1 % hydrogels 
(without 2 % unmodified 1 MDa HA). Light exposure started after 60 seconds and 
lasted for a total of 9 minutes (yellow area ). Gelation was taken as the cross-over 
between G’ and G’’ as indicated by the striped area ( ). No sol-gel transition was 
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Figure 54: Gelation kinetics and hydrogel stiffness of 1 % hydrogels (with 2 % 
unmodified 1 MDa HA) 
Gelation kinetics and hydrogel stiffness as measured by the storage (G’ ) and loss 
(G’’ ) modulus by small amplitude oscillatory time-sweep rheology of 1 % hydrogels 
(with 2 % unmodified 1 MDa HA). Light exposure started after 60 seconds and lasted 
for a total of 9 minutes (yellow area ). Gelation was taken as the cross-over between 
G’ and G’’ as indicated by the striped area ( ). No sol-gel transition was achieved for 
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Figure 55: Gelation kinetics and hydrogel stiffness of 3 % hydrogels (without 2 % 
unmodified 1 MDa HA) 
Gelation kinetics and hydrogel stiffness as measured by the storage (G’ ) and loss 
(G’’ ) modulus by small amplitude oscillatory time-sweep rheology of 3 % hydrogels 
(without 2 % unmodified 1 MDa HA). Light exposure started after 60 seconds and 
lasted for a total of 9 minutes (yellow area ). Gelation was taken as the cross-over 
between G’ and G’’ as indicated by the striped area ( ). No sol-gel transition was 
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Figure 56: Gelation kinetics and hydrogel stiffness of 3 % hydrogels (with 2 % 
unmodified 1 MDa HA) 
Gelation kinetics and stiffness as measured by the storage (G’ ) and loss (G’’ ) 
modulus by small amplitude oscillatory time-sweep rheology of 3 % hydrogels (with 2 
% unmodified 1 MDa HA). Light exposure started after 60 seconds and lasted for a 
total of 9 minutes (yellow area ). Gelation was taken as the cross-over between G’ 








































Figure 57: Stiffness of 3 % low MA and no Dopa hydrogels (without 2 % unmodified 
1 MDa HA) before and after storage 
Stiffness as measured by the storage (G’ ) and loss (G’’ ) modulus by small 
amplitude oscillatory time-sweep rheology of 3 % low MA and no Dopa hydrogels 
(without 2 % unmodified 1 MDa HA) immediately after mixing components (t = 0) and 
after storage for 1 or 8 days at RT  or 4 °C. Light exposure started after 60 seconds 
and lasted for a total of 9 minutes (yellow area ). Gelation was taken as the cross-
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Figure 58: Stiffness of 3 % low MA and low Dopa hydrogels (without 2 % unmodified 
1 MDa HA) before and after storage 
Stiffness as measured by storage (G’ ) and loss (G’’ ) modulus by small amplitude 
oscillatory time-sweep rheology of 3 % low MA and low Dopa hydrogels (without 2 % 
unmodified 1 MDa HA) after mixing components (t = 0) and after storage for 1 or 8 
days at RT or 4 °C. Light exposure started after 60 seconds and lasted for a total of 
9 minutes (yellow area ). Gelation was taken as the cross-over between G’ and G’’ 
as indicated by the striped area ( ). No sol-gel transition was achieved for the 
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Figure 59: Stiffness of 3 % high MA and no Dopa hydrogels (without 2 % unmodified 
1 MDa HA) before and after storage 
Stiffness as measured by the storage (G’ ) and loss (G’’ ) modulus by small 
amplitude oscillatory time-sweep rheology of 3 % high MA and no Dopa hydrogels 
(without 2 % unmodified 1 MDa HA) immediately after mixing components (t = 0) and 
after storage for 1 or 8 days at RT or 4 °C. Light exposure started after 60 seconds 
and lasted for a total of 9 minutes (yellow area ). Gelation was taken as the cross-
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Figure 60: Stiffness of 3 % high MA and low Dopa hydrogels (without 2 % unmodified 
1 MDa HA) before and after storage 
Stiffness as measured by the storage (G’ ) and loss (G’’ ) modulus by small 
amplitude oscillatory time-sweep rheology of 3 % high MA and low Dopa hydrogels 
(without 2 % unmodified 1 MDa HA) immediately after mixing components (t = 0) and 
after storage for 1 or 8 days at RT or 4 °C. Light exposure started after 60 seconds 
and lasted for a total of 9 minutes (yellow area ). Gelation was taken as the cross-
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5.7 Mass swelling ratio 
 
Figure 61: Mass swelling ratio 
Mass swelling ratio as determined by gravimetric analysis. Hydrogels were incubated 
in PBS (+1 % ABAM) and weight changes were recorded over 72 h. Each data point 
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Table 13: Summary of mass swelling ratio measurements from Figure 61 
Mass swelling ratio 






1 %  3 %  1 %  3 %  1 %  3 %  
Low 
MA 




±15 X X 
+ 2 % 







±25 X X 
High 
MA 
+ 0 % 
60     
±5 
70   
±10 






+ 2 % 
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5.8 Enzymatic degradation 
 
Figure 62: Enzymatic degradation 
Enzymatic degradation kinetics of hydrogels treated with 10 U/mL hyaluronidase 
(Type I, from bovine testis). The percent of hyaluronic acid released (from gel total) 
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5.9 3D cell survival 
 
Figure 63: Live/dead analysis of 3D encapsulated BMMSCs 
Representative images of BMMSC encapsulated within hydrogels and analysed 
using a live/dead viability/cytotoxicity kit. Live cells are labelled in green and dead 
cells appear magenta. Scale bar = 250 μm. 
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